Studies on Epidemic Control in Structured Populations with Applications to Influenza by Morales-Rosado, Romarie (Author) et al.
Studies on Epidemic Control in Structured Populations with Applications to
Influenza
by
Romarie Morales
A Dissertation Presented in Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy
Approved October 2015 by the
Graduate Supervisory Committee:
Carlos Castillo-Chavez, Co-Chair
Anuj Mubayi, Co-Chair
Sherry Towers, Member
ARIZONA STATE UNIVERSITY
May 2016
ABSTRACT
The 2009-10 influenza and the 2014-15 Ebola pandemics brought once again ur-
gency to an old question: What are the limits on prediction and what can be proposed
that is useful in the face of an epidemic outbreak?
This thesis looks first at the impact that limited access to vaccine stockpiles may
have on a single influenza outbreak. The purpose is to highlight the challenges faced
by populations embedded in inadequate health systems and to identify and assess
ways of ameliorating the impact of resource limitations on public health policy.
Age-specific per capita constraint rates play an important role on the dynamics of
communicable diseases and, influenza is, of course, no exception. Yet the challenges
associated with estimating age-specific contact rates have not been decisively met.
And so, this thesis attempts to connect contact theory with age-specific contact data
in the context of influenza outbreaks in practical ways. In mathematical epidemiol-
ogy, proportionate mixing is used as the preferred theoretical mixing structure and
so, the frame of discussion of this dissertation follows this specific theoretical frame-
work. The questions that drive this dissertation, in the context of influenza dynamics,
proportionate mixing, and control, are:
I. What is the role of age-aggregation on the dynamics of a single outbreak? Or
simply speaking, does the number and length of the age-classes used to model
a population make a significant difference on quantitative predictions?
II. What would the age-specific optimal influenza vaccination policies be? Or,
what are the age-specific vaccination policies needed to control an outbreak in
the presence of limited or unlimited vaccine stockpiles?
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Intertwined with the above questions are issues of resilience and uncertainty in-
cluding, whether or not data collected on mixing (by social scientists) can be used
effectively to address both questions in the context of influenza and proportionate
mixing. The objective is to provide answers to these questions by assessing the role
of aggregation (number and length of age classes) and model robustness (does the
aggregation scheme selected makes a difference on influenza dynamics and control)
via comparisons between purely data-driven model and proportionate mixing models.
ii
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Chapter 1
BACKGROUND ON INFLUENZA, SIR MODEL, VACCINE IMPLEMENTATION
AND RESEARCH FOCUS
1.1 Influenza Background and SIR Model
An influenza pandemic occurs when a non-human (novel) influenza virus steadily
and effectively enters a human population and quickly leads to a global outbreak
[1, 33, 45]. The World Health Organization (WHO) provides an influenza pandemic
alert system, with a scale ranging from Phase 1 (no known infections to humans)
to Phase 6 (a full-blown pandemic) [19, 68, 82]. The influenza viruses are classified
into types A, B and C on the basis of their core proteins. The virus types differ in
their level of spread and impact within its host populations. Types A and B can only
lead to cases in humans with a possibility of a full-blown pandemic [20, 47, 82]. The
focus of this dissertation is tied in to influenza A outbreaks in human populations.
The subtypes of influenza A viruses are determined by their membrane glycoproteins
which could be either haemagglutinin (HA) or neuraminidase (NA) [4, 82]. High mu-
tation rates and frequent genetic re-assortments of these viruses contribute to even
great variability of the HA and NA antigens. All of the currently identified 16 HA
and 9 NA subtypes of influenza A viruses are maintained in wild, aquatic bird popu-
lations. Viruses of the subtypes H1, H2 or H3, and N1 or N2 generally infect humans.
The primary transmission pathways of influenza are disseminated in the environment
by unprotected coughs and sneezes. Short-distance direct airborne transmission of
influenza viruses between individuals may occur, particularly in crowded enclosed
spaces. Hand contamination and direct inoculation of virus is another possible source
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of transmission. Influenza pathogenicity may vary from asymptomatic to fatal infec-
tion. Typical influenza symptoms include fever with abrupt onset, chills, sore throat,
cough, and are often accompanied by headache[5, 49, 52, 66, 64, 70, 76]. Influenza
weakens the immune system and can cause patients to suffer from pneumonia. In this
theoretical study the A-H1N1 2009 Pandemic is used to formulate the scenario that
highlight the results of this dissertation.
Pandemics influenza are different from Seasonal flu outbreaks. Seasonal influenza
is caused by influenza viruses that are similar to those already affecting people un-
like in the case of pandemic influenza, which is the result of emergent new influenza
viruses; that is, viruses that have had not been isolated in human populations. Sea-
sonal influenza generally causes an acute viral infection. It mainly affects children
younger than 2 years old, adults 65 years or older, pregnant women, and people of any
age experiencing chronic heart,lung kidney,liver blood or metabolic diseases (such as
diabetes), or weakened immune systems. The death rate for seasonal influenza can
be high, for example, around 56,979 deaths were attributed to influenza in the United
States of America [87].
The A-H1N1 2009 pandemic Influenza resulted in 12,469 deaths (8,868-18306) in
the United States, a surprisingly low number [44]. However unlike seasonal influenza,
the virus responsible for the A-H1N1 pandemic affected young adults. Relative pro-
tection from prior influenza exposure helps our understanding of the transmission
dynamics of influenza [14]. Key factors associated with the transmission dynamics of
influenza include variations in individuals’ susceptibility, variability in mixing among
the population, differences in infectiousness of infected people and changes in behav-
ior due to an infection outbreak [13, 72, 71]. Variations in susceptibility are often a
function of individuals’ immune system responses, which depends on the individuals’
prior history of exposure to related influenza strains [71]. Variability in mixing are
2
the result of variations in the interactions of individuals in a population [12].
Changes in behavior can be due to the levels of information (education) on the
disease and decisions to avoid or not activities that might lead to infection during an
outbreak [30]. Mixing of individuals is directly related to infection patterns in the
population [14, 13, 25]. Hence, understanding and modeling the mixing structure of a
population is one of the important aspects associated with the study of the dynamics
of a disease. In this study, our goal is to understand the impact of the variability
in a population’s mixing structures on the transmission dynamics of influenza, using
mathematical models and available mixing data. The SIR epidemic model, where S
stands for (susceptible) individuals not yet infected at the current time; I represents
individuals that are infectious, in other words, individuals that have the diseases
and can spread it to others; and R refers to individuals who were infected but no
longer have and cannot transmit the infection, underlies our modeling framework
first introduced in 1927 by Kermack and McKendrick [51]. Historically, the SIR
continuous models have been used to model infectious disease dynamics and provide
public health policy guidance [10]. A marked increase in the use of SIR transmission
models, continuous and discrete, persists [2, 3, 11, 16, 17, 40, 75].
Optimal control methodology, a powerful tool, is used to make decisions involving
complex situations. The behavior of the system, as described by the state variables, is
continuously steered via suitable control functions. The goal is to ‘adjust’ the control
in order to maximize or minimize a given objective functional. The costs associated
with a disease are incorporated in the objective function; and so, the goal to achieve
maximum reductions at a minimal cost.
There has been many studies in the literature on the dynamics of pandemic or
seasonal influenza. Ball et al.(2002) considers stochastic epidemics among a pop-
ulation partitioned into households; mixing locally within households and globally
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throughout the population. In this study, the local transmission rate was assumed
higher than the global. Their optimization analysis led them to the conclusions that
vaccinating at the very beginning of the infection is, not surprisingly, the best strat-
egy if the goal is to reduce the transmission of a fast spreading disease[6]. Merl et
al. (2009) searched for optimal vaccination strategies for influenza outbreak within a
homogeneously mixing population within a Bayesian framework. Their vaccination
strategies are adjusted to reflect the anticipated trajectory of the epidemic given the
population’s current state and approximately updated parameter estimates. That is,
the transmission rate from the previous time step is used and the vaccination strategy
is adjusted accordingly [62]. Ludkovski et al. (2010) used the work of Merl et al. in
the context of (closed) communities where medical officers can monitor each individ-
ual [59]. Their model though important- assumed homogenous mixing even though
age structure rates may have been critical [59].Finally, a volume of papers connected
to the 2009 pandemic influenza that focusses on the role of mobility, optimal control,
and more is available online [53].
Castillo-Chavez et al. (1988,1989) have studied the role of age structure on sin-
gle and multiple strain influenza models in the context of cross-immunity, a partial
“somewhat” effective natural vaccine [14, 13]. Mylius et al. (2008) focus on analyz-
ing an age structure influenza model and verifying what vaccination policy is best
to implement in order to reduce the transmission of the disease. These researches
proposed the introduction of vaccines at the beginning or at the peak of the infection
[69]. Lee et al. (2012) introduced an age structure vaccination within an optimal
control framework and addressed the question of vaccines optimality when resources
are limited.
Since the dynamics of influenza are strongly correlated with age dependent mix-
ing [13], formulating an age-structured continuous in time model that divides the
4
population into a finite number of age groupings.
In this thesis, we study the impact that variability in the contact matrix and
mixing assumptions have on the size of an influenza outbreak and on the development
of optimal vaccination strategies.
1.2 Contact Matrix
Researchers have used several methods to provide information about social con-
tacts, some of them include the use of synthetic data, while others used population
surveys [26, 28, 31, 46, 67, 96]. Lozzi et al. (2010) used an individual-based model
(IBM) to compute a variety of synthetic age specific contact matrices. Their scenarios
used data from a survey that collected contact data, supported by the Italian Na-
tional Statistical Agency (INSA). Their sample size was 55,773 individuals, grouped
into 21,075 households. Their data included socio-demographic data (e.g., school and
workplace attendance, household structure, etc.) [46]. This Italian survey considered
the difference between weekday and weekend information by dividing the sample in
three groups (first group was asked to fill the diary on a given workday (18,085 diaries
collected), the second group collected only Saturday activity (16,828), and the third
only Sunday information (16,293)). Wallinga et al. (2006) collected similar data via
a large cross sectional survey in the Netherlands. The total number of participants
that met the criteria for their analysis was 59 % (1,819 participants of 3084). Par-
ticipants were randomly selected from population records. Survey participants were
asked to provide information on how many individuals they conversed with during a
typical week, excluding household members. They divided the contacts by age using
the following six age classes: [0-5], [6-12], [13-19], [20-39], [40-59], and ≥60, groupings
in years.
Studies using specialized populations have also been carried out. Edmunds et al.
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(2006) sampled a population of undergraduate students at the University of Warwick
with the goal of estimating the number of physical contact, the stability and level
of assortative sexual encounters as a function of age. The participants were asked
to record the number of contacts and contact details over a period of three days.
Contact constituted a physical touch without conversation to an intimate contact of
sexual nature [28].
Mossong et al. 2008 carried out a large scale contact pattern survey across Europe
with the goal of parametrizing the mathematical models used to design control strate-
gies [67]. They define contact as a skin to skin physical contact (kiss or handshake)
or a two way conversation, with 3 or more words, in the physical presence of another
person but no physical contact.
Del Valle et al. (2007) used census data from the city of Portland Oregon as input
to generate a social network of synthetic population[26]. Their goal was to estimate
the age-dependent forces of infection in age-structured, compartmental models on fast
spreading diseases.
1.3 Research Focus
In the second chapter of this dissertation we identify vaccination policies aimed
at reducing the spread of disease. The policies are implemented via a simple model
and unlimited and limited vaccine stockpiles. The focus shifts to the role of vaccines
in structured age-populations in later chapters.
Publications geared towards increasing our understanding of the dynamics of a
system within age structure model include [23, 56, 25, 39, 90]; These publications,
though useful, used only an arbitrary number of age group divisions. Here, we test, in
a limited way, age group divisions and test how well mathematical formulations like
proportionate mixing does when compared to a data-driven mixing formulation[13].
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Researchers have conducted regional, city or state surveys to gather information on
how people interact with each other [39, 67, 96]. There are only a few comprehensive
surveys, and so, Mossong et al. (2008) has become the survey to “go”. Mossong et al.
(2008) goal was to define and measure explicit contacts of individuals by age groups
via the survey analysis carried out on eight European countries [67].
Computer based simulations aimed at tracking the behavior of the individuals
on a daily basis have also been carried out using, synthetic census-generated popula-
tions [26]. Theoretical general age-specific models have been introduced and analyzed
to study disease dynamics, for example proportionate mixing, preferential mixing,
standard mixing, and reduced mixing [9, 13, 25, 90]. Castillo-Chavez et al.(1989),
Busenberg et al. (1991), and Blythe’s et al. (1991) research introduce key definitions,
derivations, and properties to model mixing [9, 12, 13].
Glasser et al. (2011) tested the impact of age structured population model on
disease dynamics using different contacts data sets(Mossong et al. 2008, Wallinga et
al. 2006, Del Valle et al 2007); the focus on the kids-parents contact relations [39].
Towers et al. (2012) goal identified groups (based on age peers or family classification)
to address where social distancing would be most effective in controlling an outbreak
using an epidemic model and Mossong et al. data[90]. Del Valle et al. (2013) used
mixing patterns based on both empirical and theoretical studies to determine the
impact that different mixing functions have on disease spread. Their study tested
several mixing assumptions, including proportionate mixing . They evaluated the
role of contact data variability in an SIR type model [25]. For comparison purposes;
they divided their population on four age groups albeit no group re-arrangements
were tested and no distributions to construct in mixing assumptions were used to
address variability. Our aim, is use, to compare the mathematical proportionate
mixing approach against empirical using age-stratification to find how robust the
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mathematical formulation is to misspecification in the contact matrix. As part of our
comparison we will increase the number of age groups, consider only proportionate
mixing approach, using point estimates and variability in the point estimates.
Also, some researchers have suggested to do some form of comparison using op-
timization tools, in our case we introduce the vaccination as a form of control [25].
We do a relative cost difference analysis to asses how robust proportionate mixing is
when compared to the model output using directly the Mossong et al. (2008) survey
contact data. The goal is to assess how accurate the proportionate mixing formulation
is, and see if it is a good alternative to solving age-structure problems.
The overall objective of this thesis is to focus on the role of age stratification,
mixing, resources, and cost of disease outbreaks. The thesis involves three studies:
• Study I: The analysis of influenza vaccination strategies when supply is limited
• Study II: The study of the impact of mixing patterns and assumptions on the
dynamics of age structured populations
• Study III: The role of age-related contact structure and cost of an outbreak on
the development of optimal vaccination control policies
The third chapter will introduce the age structure and contact matrix formulations,
both making use of the survey data and contact definitions found in Mossong et
al. (2008). We will compare how well the approaches do when simulating the fast
spreading disease, influenza. In chapter 4, we will introduce vaccines as a form of
control and compare the relative cost outputs and relative cost of infection using
proportionate mixing and directly data-driven mixing models.
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Chapter 2
ROLE OF VACCINATION USE STRATEGIES WHEN SUPPLY IS LIMITED
2.1 Motivation
In 2009 Health Agencies from the US declared an influenza Pandemic on june
2009 [41, 80, 97] . The fear of a drastic increase in infection and mortality due to
transmission drove significant efforts to develop and distribute vaccines to protect
the population [92]. Some current research allocate resources assuming that we have
unlimited stockpiles of vaccines [60, 86, 91] . However only 900 million vaccine dosages
were available in 2009-2010 [34, 36, 77, 83].The challenge posed by vaccine production
restrictions and logistic distribution limitations (experienced over the course of this
pandemic) raised a key question: What is the impact of having access only to a limited
number of dosages? This work aim to shed light on finding methods to minimize the
transmission of a fast spreading disease when supply is limited.
2.2 Introduction
The World Health Organization (WHO) declared an influenza A(H1N1) pandemic
on June 11, 2009 [35, 19], that is, just a few months after a novel strain had been
identified from an infectious individual in Mexico [95]. The subsequent spread of
this new strain of H1N1 in the southern hemisphere increased the fear that a more
virulent strain would return to the northern hemisphere in the fall. Hence, efforts
to develop a vaccine that could be distributed prior to the return of H1N1 to the
northern hemisphere became a global priority. The uncertainties associated with the
magnitude and nature of this health emergency dramatically increased the demand
9
for a vaccine that was still in the design phase.
It soon became apparent that no more than 900 million vaccine dosages would
be available in 2009-2010 [74]. Wealthy nations soon purchased most of the expected
vaccine production leaving an inadequate supply available for the rest of the world.
Canada for example ordered more than 50 million dosages while the USA secured
200 million dosages [81, 88]. On the other hand the WHO was able to secure only 37
millions dosages that had to be judiciously distributed to poor nations from December
to February [29]. The first batches arrived in Canada on October 21 and in the USA in
October 19, 2009 [73, 18]. Limited supplies were used to vaccinate primarily pregnant
woman, young children, and medical personnel [7, 73, 18]. In other words, nations
that had managed to secure large supplies still had to wait several months for full
delivery, with most dosages arriving well within the second wave. The challenge posed
by vaccine production restrictions and logistic distribution limitations (experienced
over the course of this pandemic) raised several questions: What is the impact of
having access only to a limited number of dosages? What is the impact of delays
in accessing the available vaccine supply? What is the role of a large percentage of
H1N1 asymptomatic infectious individuals?
In this note, we only address the first question but its relationship to the others is
addressed briefly in the conclusion. A single-outbreak epidemiological model is used
to study the impact of a limited vaccine (not 100% effective) supply on the fall 2009-
wave in the northern hemisphere. It is assumed (a highly conservative assumption)
that the vaccine is available from the beginning of the outbreak. The role of this
vaccine is first analyzed under the assumption that the population has access to an
unlimited supply. Next, the case when the vaccine supply can only protect a small
proportion of the total population at risk is studied numerically. In both cases,
optimal control theory is used to find the optimal vaccine-strategy (unconstrained
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and constrained cases) in situations where the vaccine fails to protect a fraction of
the vaccinated populations.
2.3 Pandemic Influenza Model with Vaccination Control
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Figure 2.1: Flow Chart of the Single Outbreak Influenza Transmission Model with Vac-
cination
In this section, we use an existing single outbreak model [21, 23] modified through
the incorporation of a control function, the time-dependent vaccination rate. Two
optimal control problems are formulated and their impact on numerically derived
optimal vaccination strategies is evaluated under distinct vaccine coverage scenarios
and various values of the basic reproduction number R0 [57]. The model classifies
individuals as susceptible (S), effectively vaccinated (V ), ineffectively vaccinated (F ),
protected by vaccination (P ), latent (E), infectious (I), hospitalized (J), recovered
(R), and dead (D) (see Figure 1). Susceptible individuals are exposed to the influenza
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virus with a force of infection given by β I(t)+J(t)
N(t)
where β is the transmission rate
and N(t) denotes the total population size (N(t) = S(t) + V (t) + F (t) + P (t) +
E(t) + I(t) + J(t) + R(t)). The control function (denoted by u(t)), the vaccination
rate of susceptible individuals, is calculated under a particular set of assumptions.
Susceptible individuals (S) go to the vaccination class at the rate u(t), where  in
(0,1) is a measure of the vaccine efficacy. Therefore, (1 − ) denotes the fraction of
ineffectively (failure) vaccinated individuals per unit of time. Vaccinated individuals
go to the P (perfectly protected) class at the rate η while infected individuals enter
either the Recovered class R(t) at the rate γ1 or the Hospitalized class (J(t)) at the
rate α. Individuals in the Hospitalized class enter the Recovered class at the rate γ2
or the Death (D(t)) class at the rate δ [23]. These definitions and assumptions lead
to the following system of nonlinear differential equations that models the dynamics
of a single epidemic outbreak.
S˙(t) = −u(t)S(t)− β I(t) + J(t)
N(t)
S(t) (2.1)
V˙ (t) = u(t)S(t)− ηV (t)− β I(t) + J(t)
N(t)
V (t)
F˙ (t) = (1− )u(t)S(t)− β I(t) + J(t)
N(t)
F (t)
P˙ (t) = ηV (t)
E˙(t) = β
I(t) + J(t)
N(t)
(S(t) + V (t) + F (t))− kE(t)
I˙(t) = kE(t)− (α + γ1)I(t)
J˙(t) = αI(t)− (γ2 + δ)J(t)
R˙(t) = γ1I(t) + γ2J(t)
D˙(t) = δJ(t)
Y˙ (t) = u(t)S(t)
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The model’s basic reproduction number R0 (using the next generation operator ap-
proach [27, 93]) is given by:
R0 = β(
1
α + γ1
+
α
(α + γ1)(γ2 + δ)
). (2.2)
R0 is a measure of the transmissibility of the infectious disease when the population is
completely susceptible. Specifically, R0 accounts for the average number of secondary
cases generated by a primary case during his/her infectious period given that S(0) ≈
N(0). Typically, we have that when R0 > 1 an outbreak takes place while R0 < 1
indicates that an outbreak cannot be sustained. We take S(0) = S0, E(0) = E0, and
I(0) = I0 with S0 + E0 + I0 = N0 [I0 > and E0 > 0 and N0 >> I0 + E0]. Using the
approach in [11], we derive the final size relationship
ln
S0
S∞
< R0[1− S∞
N0
]
where the percentage of individuals recovered or dead from the infection is given by
[1− S∞
N0
].
The aim of this work is to minimize the number of infected individuals over a finite
time interval [0, T ] at a minimal cost. This outcome would be the result of implement-
ing an optimal vaccine policy during the course of an influenza epidemic outbreak.
These unconstrained (unlimited vaccines) and constrained (limited vaccines) optimal
control problems are handled using the approach illustrated in [42, 50, 54, 57]. The
objective functional to be minimized is therefore
F(u(t)) =
∫ T
0
[I(t) +
W
2
u2(t)]dt (2.3)
where the control effect is modeled by a quadratic term in u(t). The weight constant
W is a measure of the relative cost of vaccination over a finite time period. The con-
strained optimal problem with the isoperimetric-constraint (limited vaccine) consists
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of finding an optimal control function u∗(t) such that
F(u∗(t)) = minΩF(u(t)) (2.4)∫ T
0
u(t)S(t)dt = B (2.5)
where Ω = {u(t) ∈ L1(0, T )‖0 ≤ u(t) ≤ b, t ∈ [0, T ]} and subject to System (1). The
equality constraint (isoperimetric constraint) represents the total amount of vaccines
available B over the time interval [0, T ]. Constraint (5) can be reformulated in terms
of the differential equation Y˙ (t) = u(t)S(t) with the initial condition Y (0) = 0 and
final condition Y (T ) = B (added to System (1)). This way of including the isoperi-
metric constraint lets us apply the standard Pontryagin’s Maximal Principle in our
search for an optimal solution of the constrained optimization problem (additional
necessary conditions are derived in Appendix). The solution of the unconstrained op-
timal control problem excludes the Y˙ (t) equation while the solution of the constrained
problem requires the inclusion of the Y˙ (t) equation which is equivalent to (5). The
default values for initial conditions and model parameters are in Table 1. Units are
per day for all rates. These baseline values are used throughout the manuscript unless
otherwise indicated.
2.4 Simulations and Results
We present numerical simulations under two scenarios: the unconstrained optimal
vaccination and the constrained optimal one. The first case assumes that there exists
a large vaccine supply to protect the (almost) full population while the later assumes
that there is limited access to the vaccine. Our focus is on understanding the effects
of optimal vaccination strategies on the dynamics of pandemic influenza. The impact
of such controls is evaluated under different values of the basic reproductive number,
R0, and under pre-selected levels of vaccine coverage. A sensitivity analysis is carried
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out on the weight constants, on the upper bounds of the controls, and a mean vaccine
efficacy in the unconstrained optimal vaccination strategy.
2.4.1 Results in the Unconstrained Vaccine Supply Case
First, the unconstrained optimal control problem is solved under two distinct
transmissibility levels modeled by R0. Figure 2 illustrates the optimal control func-
tions computed (as a function of time) when R0 = 1.3 and R0 = 2.0 (top). The
corresponding daily incidence of the infected class with/without vaccines is displayed
in Figure 2 (bottom). The implementation of an optimal vaccine strategy reduces the
number of infected cases significantly (almost no outbreak) when R0 is low (R0 = 1.3).
We observe that maximum vaccination effort must be allocated at the beginning of
the pandemic for both values of R0. The optimal vaccination must be applied for a
longer period of time when R0 is high (R0=2.0) since there are much more infected
individuals (red solid curve in the top graph). In the absence of vaccines, a higher
peak in the incidence of infected cases over a shorter time period is detected when
R0 = 2.0 (red dotted curve in the bottom graph). Even though a considerable in-
crease in the number of vaccines is put in place, there is still an outbreak (red solid
curve in the bottom graph).
2.4.2 Sensitivity Analysis
We explore the effect of changes in model parameters on the dynamics of influenza
pandemics by carrying out a sensitivity analysis. Our sensitivity analysis focuses on
studying the role of varying the control weight constants (W ), the control upper
bounds (the maximum vaccination rate), and the vaccine efficacy. The impact of
these parameters on the fraction of cumulative infected cases is compared in the
presence and the absence of vaccines.
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Weight constant
We choose four values of the weight constants, W = 1, 102, 104, and 106 when R0 =
1.3. A comparison of results implementing optimal vaccination policies is shown in
Figure 3 under different weight constants on the control. Time series of optimal
control functions are in the top of Figure 3 (left) while the corresponding incidence of
infected individuals are in the bottom graph of Figure 3 (left). The general shapes of
the control functions are similar (monotonic decreasing in time) with large changes
in magnitude. As the weight constants are increased, the cost of vaccinations also
increase. These changes result in increases in the height of the epidemic peak that are
the result of reductions in the number of vaccines available to individuals. The impact
of the weight constants on the fraction of cumulative infected cases and vaccinated
cases is displayed as a function of R0 in the right graph. Under higher vaccination
coverage (almost 90% using the weight constants in the range of 102-106 ), the fraction
of infected cases is reduced significantly (less than 10% of the total infected cases up
to values of R0 <= 1.6).
Upper bounds of the control
We carry out a sensitivity analysis on pre-selected control upper bounds starting
from their impact on the fraction of cumulative infected cases. Four different upper
bounds on controls (a priori maximum vaccination rates for susceptible individuals)
are chosen in the range (0.05, 0.1, 0.2, 0.5). Figure 4 shows the results of implementing
optimal vaccination controls constrained by these upper bounds when R0 = 1.3.
Optimal controls are graphed at the top while the corresponding incidence of infected
individuals are plotted at the bottom (left). The cumulative fraction of infected and
vaccinated cases are shown in the right graph of Figure 4 under different values of
R0. The larger upper bound, the better impact of vaccines in reducing the number
of infected cases for all ranges of R0 values. For example, the use of the largest
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upper bound (b = 0.5) generates dramatic reductions in the number of infected cases,
regardless of the value of R0.
Vaccine efficacy
We explore the impact of changes in vaccine efficacy on the control functions as
well as on the fraction of cumulative infected cases. Figure 5 presents the results of
implementing optimal vaccination strategies using different values for vaccine efficacy
( = 0.4, 0.6, 0.8, 1) when R0 = 1.3. The optimal controls and the corresponding
incidence of infected individuals are given in Figure 5 (left). It is observed that the
vaccination strategy with larger vaccine efficacy uses less number of vaccines. For
example, the amount of vaccines with an efficacy,  <= 0.4 is almost double of those
required when  >= 0.8. The role of vaccine efficacy variation becomes clearer when
one looks at the cumulative fraction of infected cases as R0 is varied (Figure 5 right).
The optimal vaccination strategy using a higher value of vaccine efficacy ( = 0.8)
manages to keep the fraction of infected cases under 20% for most ranges of R0 (< 2)
even though it uses less vaccines.
2.4.3 Results Under Isoperimetric Constraint
We solved a constrained (isoperimetric) optimal control problem under pre-specified
isoperimetric constraints (amount of vaccines). We consider three vaccine coverage
levels (15%, 30%, and 50%). The numerical method used to solve this constrained
optimal control problem turned out to be quite sensitive to the levels of vaccine
available. As a result of the boundary conditions in the adjoint system (from the
isoperimetric constraint), convergence issues had to be addressed.
Figure 6 plots time series of the optimal vaccinations under three different vaccine
coverages (15%, 30%, and 50%). These results are contrasted with those obtained
in the absence of vaccines. The left graph displays the control functions as well as
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the resulting incidence (infected cases) when a smaller value of the control upper
bound (b=0.05) was in use. The right graph shows the results of using a larger value
for the control upper bound (b=0.2). We see that maximum vaccination rates must
always be implemented at the beginning until all the available vaccines are depleted
in both cases. The effect of two upper control bounds on the incidence of infected
cases does not seem to be significant provided that the maximum vaccination rates
are put in place at the start of the pandemic and that R0 lies in the low range (e.g
R0 = 1.3). The impact of vaccinations with 30% and 50% vaccine coverages on
the fraction of cumulative infected cases is illustrated in Figure 7. When R0 is low
enough (<= 1.4), the optimal strategy with 30% still generates significant reductions
(<= 10%). However, the benefits of the application of controls under higher vaccine
coverage (>= 50%) increase as R0 increases (R0 >= 1.5).
2.5 Conclusion
An existing influenza transmission model is used to explore the impact of optimal
vaccination policies under limited vaccine supplies (isoperimetric constrained model).
Under a rather set of optimistic assumptions (vaccines available at the beginning of a
pandemic), constrained and unconstrained optimal control problems are formulated.
The constraint imposed (a limited vaccine supply) is incorporated in the isoperimetric
optimal control problem through the addition of a differential equation with two
“boundary” conditions.
Results suggest that both optimal vaccination policies (constrained or uncon-
strained) must be implemented at the maximum vaccination rate for all ranges of R0
and at the beginning of the outbreak. There are no significant differences under the
constrained or unconstrained strategies when R0 is low (<= 1.3) and more in line
with transmissibility estimates for seasonal influenza [22]. Hence, in some sense, this
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result indicates that there is no “need” for a nation to have more than 15 % of the
vaccines needed to cover its total population. The pre-selected values of the upper
bounds on controls and vaccine efficacy levels have a significant impact on the final
size of infected cases. Increases on the upper bound of the optimal control and the
efficacy level result in a decrease in the amount of vaccines that must be administered.
In this study, the focus has been exclusively in the study of constrained and
unconstrained vaccine availability scenarios at the start of an epidemic outbreak.
In other words, the study has been quite limited as noted in the introduction with
important critical questions that should be simultaneously addressed being ignored.
The time delays associated with the process of vaccine preparation, production and
delivery of a new vaccine (around 6 months) just after a new strain was identified must
be factored in. The role of age-specific risk, asymptomatic individuals (which can
infect others) and the impact that these individuals have through their “accidental”
use of vaccine supplies, must also be considered. These ignored factors make it difficult
to mitigate the impact of super-fast spreading diseases like influenza. In summary,
for super-fast spreading diseases limitations in supply can make all the difference
particularly when R0 is large.
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Chapter 3
WHAT IS THE EFFECT OF AGGREGATION ON DISEASE DYNAMICS
3.1 Introduction
The lack of precise information on how individuals interact with each other in-
creases our difficulty in assessing the impact of a fast spreading diseases like in-
fluenza. Over the past 30 years scientist have suggested various ways of estimat-
ing contact rates given the limited and non-precise data. Collecting data via sur-
veys on samples of particular populations and using synthetic data and simulations
[9, 13, 43, 65, 67, 96].Contact mixing data collected through surveys is expensive,
whereas synthetic data, generated via models, has built in limitations [26, 67]. Re-
searches have attempted to connect limited survey with mathematical models in or-
der to improve the value of contact rates estimates. The modeling variations in-
volves mixing assumptions including proportionate mixing and data driven mixing
[9, 13, 25, 43, 65, 90].
The models that used contact data directly from the field are referred here as
empirical-data-driven mixing models, whereas the models built under theoretical mix-
ing assumptions, are named after their standard nomenclature including proportional
or preferred mixing models [39, 90].
The use of data driven mixing models have helped identify the presence of groups,
within the population of interest that have drastic impact on the model-simulated
disease dynamics. Glasser et al. (2012) used various mathematical formulations of
mixing within a Susceptible-Infected-Recovered (SIR) infection model comparing the
outcomes of theoretically driven models to those generated via empirical data-driven
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mixing formulations.Towers et al.(2012) extended the models of Glasser et al. (2012)
by incorporating interactions between grandparents and grandchildren; identifying
the role of these interactions on the transmission of a disease like influenza.
While Glasser et al.(2012) focused on the study of the use of several data-motivated
mixing formulations on incidence outcomes, Del Valle et al. (2013) instead con-
centrated on identifying the difference in final size and peak of epidemic infection
outcomes under various theoretical mixing formulations (proportionate mixing, pref-
erential mixing, reduced mixing, and data driven mixing). Del Valle et al. (2013)
used an age-structured mixing model to test the role of different age-specific mixing
assumptions (dependence on population size, average,contacts, group preference and
more) on disease dynamics using simulated data. These studies used a fixed number
of age groups and age-boundaries. They did not include vaccination. The impact of
contacts on disease dynamics within these modeling was measured using output met-
rics that included final size outbreak, peak outbreak, the average number of secondary
cases generated by an infected individual, and outbreak duration.
Our simulations show that this type of models are extremely sensitive to the use
of age-boundaries. Therefore, we study the role of uncertainty associated with the
number of age groups selected and age aggregation boundaries on disease dynamics.
We develop and analyzed a mathematical framework that addresses the effect of age
aggregation, a step needed in validating model results using empirical data. The
focus is on the role that proportionate mixing models have in the study of influenza
outbreaks. Our study begins to address the following challenges:
1. How do we develop robust age-structured models? What is the appropriate
number of age-groups? How do we make such choices given the limited survey
data? What impact do our aggregation choices have on the value on interven-
tions?
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2. How do we quantify the uncertainty generated by variations in the estimates of
age-specific contact rates on disease patterns?
The prototype selected theoretical model, proportionate mixing in this dissertation is
tested against the empirical data-driven model, generated using Mossong et al. (2008)
data. We carry this analysis in the context of a simulated influenza outbreak. Contact
matrices are constructed using the average number of contacts (from data) within the
proportionate mixing model. The generated disease dynamics are compared to those
generated when the average number of contacts data is used directly under no specific
theoretical model (data-driven mixing model) within the influenza simulation.
3.1.1 Contact Definition
In short, we constructed a contact matrix following the information given in the
study by Mossong et al. (2008) [67], a large scale survey involving Belgium, Germany,
Finland, Great Britain, Italy, Luxembourg, the Netherlands and Poland, carried out
from May 2005 to September 2006. The sampling procedure guaranteed that sample
used in the survey was representative of the whole population, in terms of geographical
spread, age, and gender. The researchers oversampled children and adolescents given
their (assumed) greater role on the transmission dynamics of influenza. A contact
was defined as a skin to skin physical interaction (kiss or handshake) or a two way
conversation with 3 or more words in the physical presence of another person but no
physical contact. The researchers gave the participants diaries to fill with the following
information: employment level, sociodemographic information, level of completed
education, household composition, age, and gender.
Participants were assigned a random day of the week and asked to record all the
contacts they made for a period of 24 hours starting at 5 am. The contacts made
that day were recorded once. The record included the location (home, work, school,
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park, ice cream shop, etc.), the duration (5 mins, 5 to 15 mins, 15 mins to 1hour,
1 to 4 hours or more ), and the frequency (e.g daily, almost daily, once or twice a
week, once or twice a month, less than once a month, once a year or first time).
Participants were asked to write down the age and gender of the person they had a
contact with. If they did not know the age of the person, they were asked to provide
an estimate of the person’s age range. The data from this survey is used to construct
a 100 x 100 contact matrix that takes into account all the relevant information from
the participants and the contacts that they made in a given day. We matched the
participants with their corresponding age and with the individuals that they made
contacts with (including their age).
3.1.2 Reciprocity
Assumption of closed population means, within the contact matrix Cij, that reci-
procity holds, that is , that the total number of contacts between age group i and age
group j must be equal to the total number of contacts between age group j and age
group i [12, 15? , 90, 84, 85, 96]. We implemented reciprocity using the approach
found in Medlock et al. (2009) [61]. Specifically, the elements of the contact matrix
are generated by dividing the number of contacts per person within age group i with
people in age group j (Cij) by the proportion of the population in age group j, that
is,
φˆij =
NCij
Nj
where N is the total population and Nj is the total population for age group j.
We correct for reciprocity by using:
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φij =
φˆij + φˆji
2
3.2 Methods
We use the age-structured SIR Model ( [10, 51]) given by the following set of
nonlinear differential equationsThe age structure model is as follows:
S˙i = −qSi
m∑
j=1
fij
Ij
Nj
I˙i = qSi
m∑
j=1
fij
Ij
Nj
− γiIi
R˙i = γiIi (3.1)
where i and j ∈ {1, 2, ...,m}, m are the number of age classes and fij is used for
different mixing formulations. We used the following two:
fij =
 Cij, directly from data driven mixingCip¯j, under proportional mixing assumption (3.2)
where Cij represents the average number of contacts that an individual in age group
i with an individual in age group j has per unit of time. Ci represents the average
number of contacts of an individual in age group i per unit of time [43] and pij,
defined below, denotes the probability of an individual in age group i contacting an
individual in age group j; It is worth observing that Cij and Ci are estimated from
the Mossong et al. (2008) data. Since we are dealing with proportionate mixing pij
is independent of i, that is pij = p¯j. The parameters for this model are listed and
defined in Table 3.1:
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Table 3.1: Parameter Definitions
Variables Definition Value Source
i Age group index n [67]
Si Susceptible population in age group i Varies –
Ii Infected population in age group i Varies –
Ri Recovered class in age group i 0 –
Parameters Definition Value Source
q Probability of Infection given a contact 0.67 [8, 58]
p¯j Proportionate mixing Varies [43, 67]
fij Effective mixing rates between age group i and age group j Varies [67]
γi Recovery Rate
1
1.5
[55]
wi Statistical weight adjustment
PopulationPercentage
SamplePercentage
Varies [67]
Nj The number of people in group j Varies –
µi Contact mean from the survey data Varies –
σ2i Variance of contacts from the survey data Varies –
µˆi Estimate of contact mean used as parameter for the TN Distribution Varies –
σˆ2i Estimate of variance used as parameter for the TN Distribution Varies –
A mixing matrix from empirical data [67] is estimated and used on the data driven
model and the proportionate formulations [13, 38, 26, 25, 43] to generate the values
used for Cij and Cj, i, j = 1, 2, ...,m . We varied the age group divisions from two up
to eight groups. For comparison purposes we concentrated on the use of proportional
mixing as the ‘null’ model so that we are able to understand the role of variations in
contact rates between the age groups under proportionate mixing and an empirically
data-driven model.
3.2.1 Proportionate Mixing
The general mixing formulation [9, 12, 13, 48] satisfy the following properties:
1. 0 < pij < 1 all i, j, and t
2.
∑m
j=1 pij = 1
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3. CipijNi = CjpjiNj
CipijNi = CjpjiNj accounts for the reciprocity demand; the total number of contacts
made by members of group i with members of group j per unit of time must be equal
to the total number of contacts made by members of group j with members of group
i per unit of time.
Proportionate mixing is the particular solution given by:
pij = p¯j =
NjCj∑n
v=1NvCv
(3.3)
where Nj is the number of people in group j, Ci =
∑m
j=1Cij is the average number
of contacts that a typical individual in group i has with anyone in the population per
unit of time; Cij is the average number of contacts of a typical individual in group
i with a typical individual of group j per unit of time [38]. We use data from the
Mossong et al. (2008) study to estimate Nj and Cij [67]. The data can be used to
generate estimates for each of the ages, from 0 to 100 years.
3.2.2 Basic Reproductive Number
The Basic reproductive number (R0) denotes the average number of secondary in-
fections generated by one infected individual during his/her infections period, assum-
ing that he/she is embedded in a fully susceptible population [13, 38, 26, 25, 43, 55].
R0, a function of demographic and epidemiological quantities, is a measure of the
transmissibility of the infectious disease in a naive population. When R0 > 1 an
outbreak is expected to take place while whenever R0 < 1 an outbreak is unlikely
to be sustained in a population. We use the methods in [94] to compute R0, under
proportionate mixing (Model 3.1). It is given by
R0 = q
∑m
i 6=j piCi
∏
γj∏m
n=1 γn
(3.4)
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The details involved in calculating R0 can be found in the Appendix. Estimates of
R0 under the data driven mixing formulation are presented later on.
3.2.3 Final Epidemic Size
Comparing how well proportionate mixing does against a data-driven mixing for-
mulation must be carried out under some metrics. In this case, we use final epidemic
size.The final epidemic size for our model, under proportionate mixing, is a solution
of the following system:
ln
(
Si(0)
Si(∞)
)
=
m∑
j=1
q
Cipj
Njγj
(Sj(0)− Sj(∞)
for, i = 1,2,3,...,m
3.3 Numerical Results
The focus of this section is on assessing the relative difference in epidemic burden
under a data driven vs. proportionate mixing models.
We proceed as follows: First we assume that the mixing and its variability are
captured in the survey or modeled explicitly. We compute the role of mean estimates
of average contact rates within each age group; secondly, we simulate the transmission
dynamics of influenza, single outbreak, comparing the outcomes under the data-driven
vs. the proportionate mixing formulations. We evaluate the role of aggregation by
considering two to eight age groupings.
The probability of infection parameter (q) is kept constant at .3334.
Case 1: We use mean estimates and variances of the estimated average con-
tact age-group rates using the Mossong et al. (2008) survey data; the estimates are
plugged in under the assumptions that the population mixes according to proportion-
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ate mixing. The variability in mean estimates was added using a truncated normal
distribution of the age groups. We used our metric, final epidemic size, in calculating
relative differences from the mean under proportionate mixing (using Mossong et al.
data (2008)).
The relative difference is calculated by subtracting the final epidemic size outcome
obtained under the model with mean estimates of average contacts of age-groups and
variability in mean estimates, both under proportionate mixing. Our simulations
(using 1000 samples) showed that the duration of the outbreak, on average, did not
last more than 30 days in all age groups. The goal was to see how robust the age
group divisions are when we considered having error in the mean estimates under
proportionate mixing.
Figure 3.1: Variability in Mean Estimates vs. Mean Estimates under Proportionate
Mixing.
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Figure 3.2: Two Standard Deviations Away from the Mean Estimates under Proportion-
ate Mixing.
Using the relative difference in final size of the disease as a metric, we notice
that the greater the number of age groupings the smaller the impact of variations
on the average number of contacts (Figure 3.1). That is, increasing the number of
age groupings makes the model results more robust (the difference gets closer to 0
regardless of variation on the mean estimates). Figure 3.2 shows the output when we
include two curves with 2 standard deviations away from the mean estimated under
proportionate mixing. In this case we notice that as we increase the number of age
groupings the standard deviations decreases.
Considering variation in the age-boundaries of the groups (for example, in two age
groups cases age 0-20, 21-100 vs 0-25,26-100), leads to similar qualitative outcomes
to those seen in the final size relative differences simulations. We observed this same
outcome as we changed from two to eight age groups. Hence, we only considered less
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than 5 changes in variations on the age boundaries. As part of our future work we
will consider carrying out extensive and systematic variations.
Case 2: The end goal is to see how well the proportionate mixing formulation in
a SIR model with parameters from a fast spreading disease like influenza does against
the same epidemic model simulated using the data driven mixing formulation, as we
increase the level of aggregation (i.e. as we increase the number of age-groupings).
The comparisons are carried out using relative final epidemic size difference between
the outputs of both models. In this case, the baseline model for computing the
relative final size difference analysis used, is the model generated via the data- driven
mixing assumption. Figure 3.3 shows the data driven model vs mean estimates under
proportionate mixing formulation. We notice that as we increase the number of
age groupings, the difference between the final size also increases. We notice, using
influenza outbreak parameters, that there exist a threshold, 5 age groupings in our
simulations, after which, the relative differences in the final epidemic size (Figure 3.3)
begin to increase.
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Figure 3.3: Data Driven Model vs Mean Estimates under Proportionate Mixing Formu-
lation.
3.4 Conclusion
The goal of this chapter has been that of setting a process for evaluating the
effect of aggregation on disease dynamics. It is driven by the question, how many
age groupings must we consider in modeling an outbreak? And, what is the effect
of changing age boundaries, number of age grouping, on disease burden? In order to
answer these questions we use parameters and age structure formulations on a fast
spreading disease like influenza. We have carried out our analysis using exclusively
contact data from the survey of Mossong et al. (2008) and have applied it to the sim-
ulation of influenza outbreaks. We have observed that proportionate mixing does well
in “matching” influenza dynamics up to a certain threshold (number of age groupings)
when compared with the data-driven mixing model. We found, that the number of
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age groupings threshold was five for our simulations. The use of proportionate mixing
formulation may therefore be ok as long as the number of age groupings is small. Also,
these results, some coinciding with the CDC group arrangements recommendations
for a fast spreading disease like influenza, do tend to vary in the influenza literature
publications [55]. Here, we noticed that changing age boundaries does not seem to
have (in our limited simulations) a drastic impact in our results as long as the number
of age groupings is small. More variations on the age groupings cut off points should
be considered.
On the other hand, if we are somewhat certain that our population is well modeled
by proportionate mixing then increasing the number of age groups may be ok [25].
Several researchers have used models to evaluate interventions (i.e. social distancing,
vaccination) albeit they have not compared the proportionate mixing formulations to
the data driven formulations [55]. The final chapter focusses on assessing the impact
of mixing formulations and assumptions on the evaluation of vaccine interventions.
The analysis in Chapter 4 will assist us in addressing questions such as, what age
groupings should receive more vaccine interventions in order to minimize the disease
burden [25, 90]? The impact of control measures on the transmission of influenza is
analyzed as we vary the level of aggregation. We have included variability on the
mean estimates of the average contacts of age-groups under proportionate mixing as
well in our analysis.
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Chapter 4
ARE THE PROPOSED VACCINATION CONTROL STRATEGIES ROBUST TO
CHANGES IN AGE-STRUCTURED MIXING PATTERNS
4.1 Introduction
Mathematical formulations, like proportionate mixing, are unlikely to fully de-
scribe how individuals actually mix. These formulations are used by modelers be-
cause they capture heterogeneity in a “simple” way and when simulated via dynami-
cal system models it may allow us to assess how disease transmission occurs and how
resources should be allocated.
Formulating and understanding human behavior has been a difficult task for re-
searchers, modelers and policy makers. The importance of understanding individual
and group behavior is critical when the goal is to minimize the transmission of a fast
spreading disease like influenza, which may demand the use of the maximum level of
possible interventions.
Recent studies have compared the value of the models when subpopulations are
assumed to mix under data-driven or proportionate mixing also or alternative mixing
formulations in the study of the dynamics of a fast spreading disease like influenza [25].
These researchers have concluded that the use of certain mathematical formulations
(including proportionate mixing) are useful because there is very limited contact data
available. However, the robustness of these conclusions have not been addressed.
There is, in fact no study in the literature, that has looked at the role of uncertainty
in the population contact behavior on the dynamics of disease transmission. Since
conducting a comprehensive population contact survey takes time, is costly, and the
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results may become obsolete rather quickly, it has become important to study the
impact of variation on estimates of contact on simulated outbreaks. We learned
that comparing proportionate mixing against data-driven mixing, on age aggregated
models, using parameters from an influenza, manage to produce comparable results
when the number of age-groupings used is small. Our results are in agreement with
those found in recent influenza publications [25].
We reviewed studies aimed at identifying best mixing models and levels of aggre-
gation under different mitigation strategies for the spread of diseases like influenza
[23, 24, 54, 56, 55]. Most of these studies failed to identify the best mitigation strate-
gies when resources are scarce or under heterogeneous mixing [23, 55, 86, 60, 89].
Some studies have focused on the study of optimal vaccination strategies under pa-
rameter uncertainty [24, 60, 89] but have failed to consider the effect of uncertainty
arising from the nature of the age-structured contacts.
In short, inaccurate applications of control policies and a lack of understanding
on the role of aggregation, that is, the number of age groupings used, may lead to
highly uncertain conclusions (e.g. erroneous decisions on what is the best target age
group). The lack of systematic uncertainty assessment may lead to undesirable dis-
ease management outcomes that include: (1) an overestimation of disease spread,
which results in greater intervention expenditures or (2) an underestimation of dis-
ease impact, which results in greater transmission and, in some cases, greater disease
mortality.
The goals of Chapter 4 include: How well does proportionate mixing do against
standard data in identifying the “best” disease vaccination control interventions poli-
cies? and, would we arrive at the same control policy recommendations when the age
aggregation scheme is changed?
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4.2 Methods
Two contact matrices, based on data driven mixing and proportionate mixing
assumptions [13, 43, 9], were generated using survey data [67]. They were used within
the SIR age-structured model below, that includes the vaccination of a fraction of the
susceptible individuals. Specifically, the model used is given by the following nonlinear
system,
S˙i = −uiSi − qSi
m∑
j=1
fij
Ij
Nj
(4.1)
I˙i = qSi
m∑
j=1
fij
Ij
Nj
− γiIi − σiIi
R˙i = uiSi + γiIi
where i and j ∈ {1, 2, ...,m} and m are the number of age groupings; fij models the
mixing formulations depending on its expression as given below:
fij =
 Cij, directly from data driven mixingCip¯j, under proportional mixing
Here, we are imputing our estimates for Cij and Ci. The susceptible individuals that
get vaccinated move to the recovered class at the per capita rate ui (referred as the
control throughout this chapter). The transmission potential of the pathogen is a
function of the population contact matrix (fij) and the probability of infection per
“approximate” contact, q (kept constant).
The comparison between proportionate and the data driven mixing formulations
is made using the total cost of disease burden (infection and vaccination) as a proxy.
Total cost is computed using direct (implementation of vaccination) and indirect cost
(number of cases generated during the outbreak). The total cost is used on the
objective function that defines the optimal control problem. It is used to identify
optimal interventions (control) rates.
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4.2.1 Optimal Control Framework
The aim of this work is to contrast the differences between data-driven and pro-
portionate mixing models via their role in minimizing the total cost. The framework
identifies optimal intervention policies that minimizes the number of infected indi-
viduals over a finite time interval [0, T ]. The results were obtained for unconstrained
(unlimited vaccines) optimal control problems [32, 56, 55, 57, 78, 86]. The objective
functional of this framework, to be minimized is given by,
min
ui
∫ T
0
m∑
i=1
(Ii + u
2
i
W
2
)dt (4.2)
The optimal control framework is (4.2) subject to (4.1). The first step is to show
analytically that for a given initial condition there exists a unique solution to the
optimal control problem.
The goal of an optimal vaccination strategy is to minimize the objective func-
tional given constraint equations and the system of equations (the integrand of (4.2)
is a convex function of u and the state system satisfies the Lipshitz property with
respect to the state variables). The existence of optimal controls is guaranteed by
standard control theory results [32, 56, 55, 57, 78, 86]. The necessary conditions,
that there exists an optimal solution, are derived using Pontryagin’s Maximum Prin-
ciple [79]. This principle converts the optimal control framework into minimizing the
Hamiltonian (H) given by:
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H =
m∑
i=1
[Ii(t) +
Wi
2
u2i (t)] (4.3)
+
m∑
i=1
λSi [−uiSi − qSi
m∑
j=1
fij
Ij
Nj
]
+
m∑
i=1
λIi [qSi
m∑
j=1
fij
Ij
Nj
− γiIi − σiIi]
+
m∑
i=1
λRi [uiSi + γiIi]
where m is the number of age groupings.
From this Hamiltonian and Pontryagin’s Maximum Principle, we obtain
Theorem: There exist the optimal control u∗(t) and corresponding state solutions,
X∗= (S∗i , I
∗
i , R
∗
i ) on 4.2 over Ω. In order for the previous statement to be true, it is
necessary that there exist adjoint variables λi(t) such that Equations 4.4 and 4.5 are
satisfied:
˙−λSi(t) = −
∂H
∂Si(t)
= −[(−ui(t)− qiSi(t),
m∑
j=1
fij
Ij(t)
Nj
)λSi(t)
+ (qiSi(t)
m∑
j=1
fij
Ij(t)
Nj
)λIi(t) + ui(t)λRi(t)]
˙−λIi(t) = −
∂H
∂Ii(t)
= −[1− (qiSi(t)fii
Ni
)λSi(t) + (qiSi(t)
fii
Ni
− γi − δi)λIi(t)
+ γiλRi(t) + δiλDi(t)]
˙−λRi(t) = −
∂H
∂Ri(t)
= 0 (4.4)
H is minimized with respect to the control (at the optimal control). We dif-
ferentiate H with respect to u on the set Ω and arrive at the following optimality
condition:
∂H
∂ui
= uiW − λSiSi = 0
ui∗ = λSi
Si
W
(4.5)
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4.2.2 Cost of Disease
Given that we want to test the effectiveness of proportionate mixing under vac-
cination control, we make use of the minimal cost of the disease (infection and
vaccination) output used in the optimal control formulation. Specifically , we use:∫ T
0
∑m
i=1(I
∗
i (t)+(u
∗
i )
2(t)W
2
)dt, which will give us the total cost of infection for a given
data set. In order to assess the effect of proportionate mixing formulation under
vaccination (control) we follow these steps:
1. Compute the minimum cost under the for the Data driven mixing assumption
(DD)∫ T
0
∑m
i=1(I
DD,∗
i (t) + (u
DD,∗
i )
2(t)W
2
)dt
2. Compute the minimum cost under the proportionate mixing assumptions (PM)∫ T
0
∑m
i=1(I
PM,∗
i (t) + (u
PM,∗
i )
2(t)W
2
)dt
3. Compare how well the model with proportionate mixing assumption did against
the model with the data driven mixing assumptions by comparing their respec-
tive minimum cost.
In order to follow through the comparison outlined in the previous step, we do
the following:
1. Use the control solution (uˆPM,∗i (t)) obtained under the proportionate mixing as-
sumptions and apply it to the Data Driven dynamic epidemic model to compute
IDD,∗i (t)
2. Calculate the Cost of an imperfect control
∫ T
0
∑m
i=1(I
DD,∗
i (t) + (u
PM,∗
i )
2(t)W
2
)dt
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• uPM,∗i (t) is the control under Proportionate Mixing assumptions
• IDD,∗i (t) lnfected individuals using Data Driven Mixing State equations
with Proportionate Mixing control
3. Calculate Relative Cost difference
•
∫ T
0
∑m
i=1(I
DD,∗
i (t)+(u
DD,∗
i )
2(t)W
2
)dt−∫ T0 ∑mi=1(IPM,∗i (t)+(uPM,∗i )2(t)W2 )dt∫ T
0
∑m
i=1(I
DD,∗
i (t)+(u
DD,∗
i )
2(t)W
2
)dt
We analyze the relative cost difference of the data driven model against the one
generated, via the proportionate mixing model, as we increase the number of age
stratification (groupings) from 2 to 6 age groupings. We use the recommended age
group structured from the Center of Disease and Control for vaccination for influenza
like disease. For comparison purposes, we also incorporate age group division (group-
ing) found in the literature [55].
4.3 Results
We want to find out how well the proportionate mixing model captures the dy-
namics of an outbreak as we increase the level of age structure(groupings) under
vaccination. We evaluate our results using relative cost differences between the data-
driven mixing and the proportionate mixing models [56, 55].Seeing wether or not
variation of age boundaries (cut off points) in the age structure grouping changes our
results, is important. The age structure grouping recommendations from the CDC
for influenza vaccination and the age structure grouping from Lee et al. (2012) were
used to apply the age aggregation cut offs.
The results below are collected using data driven mixing (Mossong or M;creating
subgroups of contacts within the contact matrix under the data driven mixing formu-
lation ), proportionate mixing (SDPM; mean contacts with mixing rates proportional
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to both contacts in the group and population of the group), and variation in aver-
age contacts under proportionate mixing (TNPM; mean contacts with variability and
mixing rates proportion to both group-contacts and group population).
The results below are collected in two subsections. The first collects the output
values generated using the CDC framework; the second set of results collects the
results generated using Lee et al. (2012) age group framework. It is worth nothing
that within each framework, we present the relative cost difference of using the pro-
portionate mixing under standard data (SDPM) and including variability or error in
the proportionate mixing formulation (TNPM).
4.3.1 CDC Age Group Framework
The graph below shows the relative cost difference when using Mossong vs. SDPM
and mean TNPM contact matrix set up. We notice that as we increase the number
of age groups the relative difference increases in both cases. The relative difference
on the Mossong vs SDPM output increases significantly after 4 age groups. In the
case of Mossong vs mean TNPM we notice there is a higher relative cost difference
in every age group division. The difference also increases as we increase the number
of age groups (Figure 4.1). We also include a trend line with the relative difference
plots.
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Figure 4.1: Relative Cost Difference using the CDC Framework.
We observe the vaccination policies must be implemented at a maximum rate from
the very beginning of the transmission of the epidemic (Figure 4.2) as expected. We
observed similar results regardless of the number of age groupings, 2 to 6. Here, we
present the output of the control when implementing different type of mixing assump-
tions (data driven mixing = Mossong, Mean estimates = SDPM, and variability on
the mean estimates = TNPM)
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Figure 4.2: Output of the Control Over Time used to Minimize the Infected Individuals:
2 Age Groups Example.
The output of the incidence curve is shown in Figure 4.3. We notice that the
incidence output is qualitatively similar when using proportionate vs. using the data
driven mixing (Figure 4.3).
Figure 4.3: Output of the Incidence over Time of Infected Individuals from Age Group
1 to 6 using 3 Different Approaches.
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4.3.2 Lee et al. Age Group Framework
Figure 4.4 shows the relative cost difference when we use the age grouping ar-
rangement as per Lee et al. (2012). The relative cost difference in both data driven
and proportionate mixing cases increases as we increase the number of age groups.
The difference using the SDPM vs Mossong regroup data is smaller in the first 4 age
groups divisions.
Figure 4.4: Relative Cost difference .
43
Figure 4.5: Output of the Incidence over Time of Infected Individuals from Age Group
1 to 6 using 3 Different Approaches.
We compared both outcomes and noticed that regardless of the difference in age
group cut off points they both have the relative cost difference consistent until 3
age groupings. After this threshold value the trends changes significantly. This could
suggest a cut off point of 3 age groupings when implementing vaccine control measures
for a fast spreading disease like influenza.
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4.4 Conclusion
This study has focused on finding how robust the mathematical formulation is to
misspecification in the contact matrix; that is, how well models under the proportion-
ate mixing do when compared to models under data driven mixing in the absence or
presence of controls (vaccination). The comparisons where carried out when optimal
intervention rates that guaranteed minimal total cost of intervention. Finding out
wether or not a cut off on the number of age-groupings played a role on the relative
cost of the implementation of a vaccine has been part of our analysis. We also study
wether or not policy recommendations for age group structured model differed when
compared to a non age group structured models. We noticed that age structure and
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non age-structured models led to similar vaccination policy recommendation, namely
that the majority of resources must be implemented at the beginning of the transmis-
sion of a fast disease, like influenza. The use of different age groupings; one following
CDC age-grouping recommendations and based on the literature, did not have a sig-
nificant impact on the total cost of infection up to a particular threshold. The use
of 3 age groupings still provided acceptable relative cost difference independently of
the age group framework used. Hence, we see that proportionate mixing works well
under different age grouping as long as we keep the age groupings below a threshold.
Naturally, the threshold may change if we use a different data set. We recommend
checking several age grouping cut off points to see when the use of proportionate
mixing leads to possibly unacceptable results.
The results on this chapter when assumed unlimited vaccination resources. As we
noted in the second chapter (Vaccination strategies when supply is limited) we are
planning to incorporate the limited constraint (isoperimetric optimal control problem)
in this setting. In our second chapter we identified the range of convergence, however
when dealing with age structure models, increasing the number of age groups, made
it impossible to identify the convergence range. This challenge will be addressed in
future work.
Overall it can be argued that using a population that follows proportionate mixing will
be robust to mis- specifications up to a certain critical number of age group divisions,
what would this critical value be will depend on the data, model framework, and
age-boundaries.
46
Chapter 5
IMPLICATIONS FROM DATA-DRIVEN MECHANISTIC MODELING
APPROACH AND MANAGEMENT RESOURCE ALLOCATIONS TO REDUCE
IMPAT OF FAST SPREADING DISEASE
5.0.1 Goal of Thesis
Dynamical models are often used to evaluate interventions for control of infectious
diseases in a population. Population’s mixing/contact data are of great importance if
the goal is to parametrize age structured models or if the aim is to look at age-specific
control policies within some realistic scenarios. Contact data is difficult to obtain and
most often not available. Hence, modelers have constructed age-dependent mathe-
matical formulations like proportionate mixing that allows them to estimate mixing
patterns with limited contact data and, consequently, studies that quantify disease
dynamics under these mixing models often the underestimation or overestimation
disease burden. In this thesis, we investigate the robustness of misspecification in
age-dependent contact matrices (via a mathematical formulation like proportionate
mixing) on the transmission dynamics and control of a communicable disease. We
compare proportionate and data-driven mixing in the context of influenza outbreaks
and vaccination in order to identify optimal vaccination strategies when supply is
limited. We also look at the impact of contact estimates in mixing patterns and
variations on disease disease dynamics within age structure populations. We also
study the role of age-related contact structures and cost within an outbreak when
vaccination is available.
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5.0.2 Review of Results
The second chapter addresses the optimal distribution of vaccination resources
needed to minimize the spread of a disease, particularly, when resources are limited.
We find that vaccination resources must be implemented at the beginning of an out-
break regardless of stockpile size. We further conclude that whenever transmission
of the disease is low, vaccinating may not have a significant effect in reducing the
number of infected individuals. Results are sensitive to mixing patterns in the pop-
ulation i.e., the way individuals interact with each other and their rate of contacts.
Hence, we also explore the role of age-structured mixing on disease transmission dy-
namics. There are rather few published papers that attempt to collect comprehensive
data from surveys on the number of contacts that an individual has on a particular
day. Several papers introduce mathematical formulations on ways that individuals
interact and their impact on disease dynamics. Proportionate mixing on the dynamic
results are compared to those obtained when the survey data was used directly. The
relative difference in final epidemic size when the number of age groups (from 2 to 8
age-groups) are varied are also compared.
Our results suggest that the relative difference in final outbreak size for models is
low (with increases in number of age groups in the models) when the number of age
groups is small.
We develop an optimal control framework (expansion from the second chapter) to
include age structure and find that the maximum amount of vaccines available must
be distributed at the beginning of an outbreak regardless of the number of the age
groupings considered; the same outcome coming from non age-structured models. Of
course, how the vaccine must be distributed within need not be uniform.
We compare the relative cost of between the output of vaccination data-driven
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model and proportionate mixing. The results show that the relative cost difference will
increase as we increase the number of age groupings. Further, significant difference are
observed when the number of age-groupings increases. Here, using a four age group
(or lower) under proportionate mixing produces accurate results on to the amount of
control needed to restrain the spread of an influenza like disease spread.
Overall proportionate mixing is a useful formulation, when there is a lack of in-
formation or mis-specification on contact patterns (contact matrix) as long as the
age-grouping used is low.
5.0.3 Caveats and Future Work
This work should be expanded to consider the implications associated with the
limitations of our current study, for example, verifying if similar results are generated
when we consider a limited vaccine stockpile or other forms of control, like social
distancing. Also, the results must be validated and compared using various data sets
(ie. Episims [25]). Other potential expansion may be needed to study the role of the
dominant eigenvalue of the contact matrix on the disease dynamics as we increase the
number of age groups. We should also consider alternative mathematical formulations
in constructing contact matrices like, preferential mixing and reduced mixing.
We plan to use bootstrapping techniques to examine model outcomes when contact
patterns are varied. Finally, we plan to consider testing this technique on various fast
spreading diseases.
49
REFERENCES
[1] Defense Health Agency. Questions and answers influenza - pandemic.
[2] Linda JS Allen and Amy M Burgin. Comparison of deterministic and stochastic
sis and sir models in discrete time. Mathematical biosciences, 163(1):1–33, 2000.
[3] Linda JS Allen and P Van Den Driessche. The basic reproduction number in some
discrete-time epidemic models. Journal of Difference Equations and Applications,
14(10-11):1127–1147, 2008.
[4] Susan J Baigent and John W McCauley. Influenza type a in humans, mammals
and birds: determinants of virus virulence, host-range and interspecies transmis-
sion. Bioessays, 25(7):657–671, 2003.
[5] Michael G Baker, Craig N Thornley, Clair Mills, Sally Roberts, Shanika Perera,
Julia Peters, Anne Kelso, Ian Barr, Nick Wilson, et al. Transmission of pandemic
a/h1n1 2009 influenza on passenger aircraft: retrospective cohort study. Bmj,
340, 2010.
[6] Frank G Ball and Owen D Lyne. Optimal vaccination policies for stochastic
epidemics among a population of households. Math Biosci, 177-178:333–54, 2002.
[7] Nicole E Basta, Dennis L Chao, M Elizabeth Halloran, Laura Matrajt, and
Ira M Longini, Jr. Strategies for pandemic and seasonal influenza vaccination of
schoolchildren in the united states. Am J Epidemiol, 170(6):679–86, Sep 2009.
[8] Faina Berezovsky, Georgy Karev, Baojun Song, and Carlos Castillo-Chavez. A
simple epidemic model with surprising dynamics. Math Biosci Eng, 2(1):133–52,
Jan 2005.
[9] SP Blythe, C Castillo-Chavez, JS Palmer, and M Cheng. Toward a unified theory
of sexual mixing and pair formation. Mathematical biosciences, 107(2):379–405,
1991.
[10] Fred Brauer. Mathematical epidemiology is not an oxymoron. BMC Public
Health, 9(Suppl 1):S2, 2009.
[11] Fred Brauer, Zhilan Feng, and Carlos Castillo-Chavez. Discrete epidemic models.
Math Biosci Eng, 7(1):1–15, Jan 2010.
[12] S Busenberg and C Castillo-Chavez. A general solution of the problem of mixing
of subpopulations and its application to risk- and age-structured epidemic models
for the spread of aids. IMA J Math Appl Med Biol, 8(1):1–29, 1991.
[13] C Castillo-Chavez, H W Hethcote, V Andreasen, S A Levin, and W M Liu.
Epidemiological models with age structure, proportionate mixing, and cross-
immunity. J Math Biol, 27(3):233–58, 1989.
50
[14] Carlos Castillo-Chavez. Cross-immunity in the dynamics of homogenous and
heterogeneous populations, volume 87. Mathematical Sciences Institute, Cornell
University, 1987.
[15] Carlos Castillo-Chavez and Shu-Fang Hsu Schmitz. The evolution of age-
structured marriage functions: It takes two to tango. In Structured-Population
Models in Marine, Terrestrial, and Freshwater Systems, pages 533–553. Springer,
1997.
[16] Carlos Castillo-Chavez and Abdul-Aziz Yakubu. Discrete-time sis models with
complex dynamics. Nonlinear Analysis: Theory, Methods &amp; Applications,
47(7):4753–4762, 2001.
[17] Carlos Castillo-Cha´vez and Abdul-Aziz Yakubu. Discrete-time sis models with
simple and complex population dynamics. IMA VOLUMES IN MATHEMATICS
AND ITS APPLICATIONS, 125:153–164, 2002.
[18] CDC. The 2009 h1n1 pandemic: Summary highlights, april 2009-april 2010.
[19] Margaret Chan. World now at the start of 2009 influenza pandemic. 2009.
[20] Jiezhong Chen, Yi-Mo Deng, et al. Influenza virus antigenic variation, host
antibody production and new approach to control epidemics. Virol J, 6(30):3,
2009.
[21] G Chowell, C E Ammon, N W Hengartner, and J M Hyman. Transmission dy-
namics of the great influenza pandemic of 1918 in geneva, switzerland: Assessing
the effects of hypothetical interventions. J Theor Biol, 241(2):193–204, Jul 2006.
[22] G Chowell, M A Miller, and C Viboud. Seasonal influenza in the united states,
france, and australia: transmission and prospects for control. Epidemiol Infect,
136(6):852–64, Jun 2008.
[23] Gerardo Chowell, Ce´cile Viboud, Xiaohong Wang, Stefano M Bertozzi, and
Mark A Miller. Adaptive vaccination strategies to mitigate pandemic influenza:
Mexico as a case study. PLoS One, 4(12):e8164, 2009.
[24] Damian Clancy and Nathan Green. Optimal intervention for an epidemic model
under parameter uncertainty. Math Biosci, 205(2):297–314, Feb 2007.
[25] Sara Y Del Valle, J M Hyman, and Nakul Chitnis. Mathematical models of con-
tact patterns between age groups for predicting the spread of infectious diseases.
Math Biosci Eng, 10(5-6):1475–97, 2013.
[26] Sara Y Del Valle, James M Hyman, Herbert W Hethcote, and Stephen G Eu-
bank. Mixing patterns between age groups in social networks. Social Networks,
29(4):539–554, 2007.
[27] O Diekmann and JAP Heesterbeek. Mathematical epidemiology of infectious
diseases: model building, analysis and interpretation. 2000. Wiley, 2000.
51
[28] W J Edmunds, G Kafatos, J Wallinga, and J R Mossong. Mixing patterns and
the spread of close-contact infectious diseases. Emerg Themes Epidemiol, 3:10,
2006.
[29] Martin Enserink. The challenge of getting swine flu vaccine to poor nations.
[30] Eli P Fenichel, Carlos Castillo-Chavez, MG Ceddia, Gerardo Chowell, Paula
A Gonzalez Parra, Graham J Hickling, Garth Holloway, Richard Horan, Ben-
jamin Morin, Charles Perrings, et al. Adaptive human behavior in epidemiologi-
cal models. Proceedings of the National Academy of Sciences, 108(15):6306–6311,
2011.
[31] Neil M Ferguson, Matt J Keeling, W John Edmunds, Raymond Gani, Bryan T
Grenfell, Roy M Anderson, and Steve Leach. Planning for smallpox outbreaks.
Nature, 425(6959):681–685, 2003.
[32] WH Fleming and RW Rishel. Deterministic and stochastic optimal control. 1975.
[33] Staff: Centers for Disease Control and Prevention. Cdc resources for pandemic
flu.
[34] Carlos Franco-Paredes, Peter Carrasco, and Jose IS Preciado. The first influenza
pandemic in the new millennium: lessons learned hitherto for current control
efforts and overall pandemic preparedness. Journal of immune based therapies
and vaccines, 7(1):2, 2009.
[35] Christophe Fraser, Christl A Donnelly, Simon Cauchemez, William P Hanage,
Maria D Van Kerkhove, T De´irdre Hollingsworth, Jamie Griffin, Rebecca F
Baggaley, Helen E Jenkins, Emily J Lyons, et al. Pandemic potential of a strain
of influenza a (h1n1): early findings. science, 324(5934):1557–1561, 2009.
[36] Martin Friede, Laszlo Palkonyay, Claudia Alfonso, Yuri Pervikov, Guido Torelli,
David Wood, and Marie Paule Kieny. Who initiative to increase global and
equitable access to influenza vaccine in the event of a pandemic: supporting
developing country production capacity through technology transfer. Vaccine,
29:A2–A7, 2011.
[37] Raymond Gani, Helen Hughes, Douglas Fleming, Thomas Griffin, Jolyon Med-
lock, and Steve Leach. Potential impact of antiviral drug use during influenza
pandemic. Emerg Infect Dis, 11(9):1355–62, 2005.
[38] G P Garnett and R M Anderson. Sexually transmitted diseases and sexual
behavior: insights from mathematical models. J Infect Dis, 174 Suppl 2:S150–
61, Oct 1996.
[39] John Glasser, Zhilan Feng, Andrew Moylan, Sara Del Valle, and Carlos Castillo-
Chavez. Mixing in age-structured population models of infectious diseases. Math
Biosci, 235(1):1–7, Jan 2012.
52
[40] Paula A Gonza´lez-Parra, Sunmi Lee, Leticia Vela´zquez, and Carlos Castillo-
Chavez. A note on the use of optimal control on a discrete time model of influenza
dynamics. Math Biosci Eng, 8(1):183–97, Jan 2011.
[41] Kathy Hancock, Vic Veguilla, Xiuhua Lu, Weimin Zhong, Ebonee´ N Butler,
Hong Sun, Feng Liu, Libo Dong, Joshua R DeVos, Paul M Gargiullo, et al.
Cross-reactive antibody responses to the 2009 pandemic h1n1 influenza virus.
New England Journal of Medicine, 361(20):1945–1952, 2009.
[42] Elsa Hansen and Troy Day. Optimal control of epidemics with limited resources.
J Math Biol, 62(3):423–51, Mar 2011.
[43] Herbert W Hethcote. An age-structured model for pertussis transmission. Math-
ematical biosciences, 145(2):89–136, 1997.
[44] Kyung-Wook Hong, Hee Jin Cheong, Won Suk Choi, Jacob Lee, Seong-Heon
Wie, Ji Hyeon Baek, Hyo Youl Kim, Hye Won Jeong, and Woo Joo Kim. Clinical
courses and outcomes of hospitalized adult patients with seasonal influenza in
korea, 2011–2012: Hospital-based influenza morbidity &amp; mortality (himm)
surveillance. Journal of Infection and Chemotherapy, 20(1):9–14, 2014.
[45] Premier Safety Institute. Epidemic and pandemic influenza and respiratory ill-
ness.
[46] Fabrizio Iozzi, Francesco Trusiano, Matteo Chinazzi, Francesco C Billari, Emilio
Zagheni, Stefano Merler, Marco Ajelli, Emanuele Del Fava, and Piero Manfredi.
Little italy: an agent-based approach to the estimation of contact patterns-
fitting predicted matrices to serological data. PLoS Comput Biol, 6(12):e1001021,
2010.
[47] Marika K Iwane, Kathryn M Edwards, Peter G Szilagyi, Frances J Walker,
Marie R Griffin, Geoffrey A Weinberg, Charmaine Coulen, Katherine A Poehling,
Laura P Shone, Sharon Balter, et al. Population-based surveillance for hospital-
izations associated with respiratory syncytial virus, influenza virus, and parain-
fluenza viruses among young children. Pediatrics, 113(6):1758–1764, 2004.
[48] John A Jacquez, Carl P Simon, James Koopman, Lisa Sattenspiel, and Timothy
Perry. Modeling and analyzing hiv transmission: the effect of contact patterns.
Mathematical Biosciences, 92(2):119–199, 1988.
[49] Denise J Jamieson, Margaret A Honein, Sonja A Rasmussen, Jennifer L Williams,
David L Swerdlow, Matthew S Biggerstaff, Stephen Lindstrom, Janice K Louie,
Cara M Christ, Susan R Bohm, et al. H1n1 2009 influenza virus infection during
pregnancy in the usa. The Lancet, 374(9688):451–458, 2009.
[50] E Jung, Suzanne Lenhart, and Z Feng. Optimal control of treatments in a two-
strain tuberculosis model. Discrete and Continuous Dynamical Systems Series
B, 2(4):473–482, 2002.
53
[51] William O Kermack and Anderson G McKendrick. Contributions to the math-
ematical theory of epidemics. ii. the problem of endemicity. Proceedings of the
Royal society of London. Series A, 138(834):55–83, 1932.
[52] Fan-kun Kong. Pilot clinical study on a proprietary elderberry extract: effi-
cacy in addressing influenza symptoms. Online Journal of Pharmacology and
Pharmacokinetics, 5:32–43, 2009.
[53] Yang Kuang. Special issue on mathematical models, challenges, and lessons
learned from the 2009 a/h1n1 influenza pandemic. Math Biosci Eng, 8(1):1–238,
2011.
[54] Sunmi Lee, Gerardo Chowell, and Carlos Castillo-Cha´vez. Optimal control of
influenza pandemics: the role of antiviral treatment and isolation. Journal of
Theoretical Biology, 265:136–150, 2010.
[55] Sunmi Lee, Michael Golinski, and Gerardo Chowell. Modeling optimal age-
specific vaccination strategies against pandemic influenza. Bull Math Biol,
74(4):958–80, Apr 2012.
[56] Sunmi Lee, Romarie Morales, and Carlos Castillo-Chavez. A note on the use
of influenza vaccination strategies when supply is limited. Math Biosci Eng,
8(1):171–82, Jan 2011.
[57] Suzanne Lenhart and John T Workman. Optimal control applied to biological
models. CRC Press, 2007.
[58] Ira M Longini, M Elizabeth Halloran, Azhar Nizam, and Yang Yang. Containing
pandemic influenza with antiviral agents. American journal of epidemiology,
159(7):623–633, 2004.
[59] Michael Ludkovski and Jarad Niemi. Optimal dynamic policies for influenza
management. Statistical Communications in Infectious Diseases, 2(1), 2010.
[60] Laura Matrajt, Jr and Ira M Longini. Optimizing vaccine allocation at different
points in time during an epidemic. PLoS One, 5(11):e13767, 2010.
[61] Jan Medlock, Lauren Ancel Meyers, and Alison Galvani. Optimizing allocation
for a delayed influenza vaccination campaign. PLoS Curr, 1:RRN1134, 2009.
[62] Daniel Merl, Leah R Johnson, Robert B Gramacy, and Marc Mangel. A statis-
tical framework for the adaptive management of epidemiological interventions.
PLoS One, 4(6):e5807, 2009.
[63] Christina E Mills, James M Robins, and Marc Lipsitch. Transmissibility of 1918
pandemic influenza. Nature, 432(7019):904–906, 2004.
[64] Arnold S Monto, A Webster, and Oliver Keene. Randomized, placebo-controlled
studies of inhaled zanamivir in the treatment of influenza a and b: pooled efficacy
analysis. Journal of Antimicrobial Chemotherapy, 44(suppl 2):23–29, 1999.
54
[65] Benjamin R Morin, Carlos Castillo-Chavez, Shu-Fang Hsu Schmitz, Anuj
Mubayi, and Xiahong Wang. Notes from the heterogeneous: a few observations
on the implications and necessity of affinity. Journal of biological dynamics,
4(5):456–477, 2010.
[66] Michael R Moser, Thomas R Bender, Harold S Margolis, Gary R Noble, Alan P
Kendal, and Donald G Ritter. An outbreak of influenza aboard a commercial
airliner. American journal of epidemiology, 110(1):1–6, 1979.
[67] Joe¨l Mossong, Niel Hens, Mark Jit, Philippe Beutels, Kari Auranen, Rafael
Mikolajczyk, Marco Massari, Stefania Salmaso, Gianpaolo Scalia Tomba, Jacco
Wallinga, et al. Social contacts and mixing patterns relevant to the spread of
infectious diseases. PLoS medicine, 5(3):e74, 2008.
[68] Sandra Mounier-Jack and Richard J Coker. How prepared is europe for pandemic
influenza? analysis of national plans. The Lancet, 367(9520):1405–1411, 2006.
[69] Sido D Mylius, Thomas J Hagenaars, Anna K Lugne´r, and Jacco Wallinga. Op-
timal allocation of pandemic influenza vaccine depends on age, risk and timing.
Vaccine, 26(29-30):3742–9, Jul 2008.
[70] KG Nicholson, FY Aoki, ADME Osterhaus, S Trottier, O Carewicz, CH Mercier,
A Rode, N Kinnersley, P Ward, et al. Efficacy and safety of oseltamivir
in treatment of acute influenza: a randomised controlled trial. The Lancet,
355(9218):1845–1850, 2000.
[71] M Nuno, C Castillo-Chavez, Z Feng, and M Martcheva. Mathematical mod-
els of influenza: the role of cross-immunity, quarantine and age-structure. In
Mathematical Epidemiology, pages 349–364. Springer, 2008.
[72] M Nuno, Zhilan Feng, Maia Martcheva, and Carlos Castillo-Chavez. Dynamics
of two-strain influenza with isolation and partial cross-immunity. SIAM Journal
on Applied Mathematics, 65(3):964–982, 2005.
[73] Canadian Institute of Health. The impact of the h1n1 pandemic on canadian
hospitals.
[74] World Health Organization. Update on a(h1n1) pandemic and seasonal vaccine
availability, 2009.
[75] Paula Andrea´ Gonzalez Parra. Constrained optimal control for a multi-group
discrete time influenza model. 2012.
[76] Patrick H Peters, Stefan Gravenstein, Paul Norwood, Veerle De Bock, Anthony
Van Couter, Michael Gibbens, Tony-Andrea Von Planta, and Penelope Ward.
Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail
older population. Journal of the American Geriatrics Society, 49(8):1025–1031,
2001.
[77] Gregory A Poland. Vaccines against avian influenzaa race against time. New
England Journal of Medicine, 354(13):1411–1413, 2006.
55
[78] Lev Semenovich Pontryagin. Mathematical theory of optimal processes. CRC
Press, 1987.
[79] LS Pontryagin, VG Boltyanskii, RV Gamkrelidze, and E Mishchenko. The math-
ematical theory of optimal processes (international series of monographs in pure
and applied mathematics). Interscience, New York, 1962.
[80] Anne M Presanis, Daniela De Angelis, Angela Hagy, Carrie Reed, Steven Riley,
Ben S Cooper, Lyn Finelli, Paul Biedrzycki, Marc Lipsitch, et al. The severity of
pandemic h1n1 influenza in the united states, from april to july 2009: a bayesian
analysis. PLoS medicine, 6(12):e1000207, 2009.
[81] Associated Press. 40 million doses of h1n1 vaccine will be burned.
[82] World Health Organization. Global Influenza Programme. Pandemic influenza
preparedness and response: a WHO guidance document. World Health Organi-
zation, 2009.
[83] Rino Rappuoli and Philip R Dormitzer. Influenza: options to improve pandemic
preparation. Science, 336(6088):1531–1533, 2012.
[84] S-F Hsu Schmitz and C Castillo-Chavez. Parameter estimation in non-closed
social networks related to dynamics of sexually transmitted diseases, 1994.
[85] Shu-Fang Hsu Schmitz and Carlos Castillo-Chavez. Completion of mixing matri-
ces for non-closed social networks. In World Congress of Nonlinear Analysts’ 92:
Proceedings of the First World Congress of Nonlinear Analysts, Tampa, Florida,
August 19-26, 1992, volume 1, page 3163. Walter de Gruyter, 1996.
[86] Eunha Shim. Optimal strategies of social distancing and vaccination against
seasonal influenza. Math Biosci Eng, 10(5-6):1615–34, 2013.
[87] Jessica L Silvaggio, A Bearden, P Marquez, D Terashita, B Schwartz, and L Mas-
cola. The influence of a mandate for influenza vaccination or masking of health-
care personnel: Experience from a large urban area. In 2015 CSTE Annual
Conference. Cste, 2015.
[88] Christina Spencer. Canada lends mexico 5m doses of h1n1 vaccine.
[89] Matthew W Tanner, Lisa Sattenspiel, and Lewis Ntaimo. Finding optimal vac-
cination strategies under parameter uncertainty using stochastic programming.
Mathematical biosciences, 215(2):144–151, 2008.
[90] S Towers and Z Feng. Social contact patterns and control strategies for influenza
in the elderly. Mathematical biosciences, 240(2):241–249, 2012.
[91] Ashleigh Tuite, David N Fisman, Jeffrey C Kwong, and Amy Greer. Optimal
pandemic influenza vaccine allocation strategies for the canadian population.
PLoS Curr, 2:RRN1144, 2010.
56
[92] Zoltan Vajo, Ferenc Tamas, Laszlo Sinka, and Istvan Jankovics. Safety and
immunogenicity of a 2009 pandemic influenza a h1n1 vaccine when adminis-
tered alone or simultaneously with the seasonal influenza vaccine for the 2009–
10 influenza season: a multicentre, randomised controlled trial. The Lancet,
375(9708):49–55, 2010.
[93] P van den Driessche and James Watmough. Reproduction numbers and sub-
threshold endemic equilibria for compartmental models of disease transmission.
Math Biosci, 180:29–48, 2002.
[94] Pauline Van den Driessche and James Watmough. Reproduction numbers and
sub-threshold endemic equilibria for compartmental models of disease transmis-
sion. Mathematical biosciences, 180(1):29–48, 2002.
[95] Josep Vaque´ Rafart, Julita Gil Cuesta, and Mar´ıa Brotons Agullo´. Principales
caracter´ısticas de la pandemia por el nuevo virus influenza a (h1n1). Medicina
cl´ınica, 133(13):513–521, 2009.
[96] Jacco Wallinga, Peter Teunis, and Mirjam Kretzschmar. Using data on social
contacts to estimate age-specific transmission parameters for respiratory-spread
infectious agents. Am J Epidemiol, 164(10):936–44, Nov 2006.
[97] Laura Forsberg White, Jacco Wallinga, Lyn Finelli, Carrie Reed, Steven Riley,
Marc Lipsitch, and Marcello Pagano. Estimation of the reproductive number
and the serial interval in early phase of the 2009 influenza a/h1n1 pandemic in
the usa. Influenza and Other Respiratory Viruses, 3(6):267–276, 2009.
57
APPENDIX A
OPTIMAL CONTROL
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A.1 Optimal Control Formulation
The goal is to find an optimal vaccination strategy that minimizes Objective
Functional (3) given Criterion (4) and the regularity of System of equations (1) (the
integrand of F is a convex function of u and the the state system satisfies the Lipshitz
property with respect to the state variables). The existence of optimal controls is
guaranteed by standard results in control theory [32]. The necessary conditions that
optimal solutions must satisfy are derived using Pontryagin’s Maximum Principle
[79]. This principle converts Systems (1) and (4) into minimizing the Hamiltonian H
given by
H = I(t) +
W
2
u2(t) (A.1)
+ A1(t){−u(t)S(t)− β
N(t)
(I(t) + J(t))S(t)}
+ A2(t){u(t)S(t)− ηV (t)− β
N(t)
(I(t) + J(t))V (t)}
+ A3(t){(1− )u(t)S(t)− β
N(t)
(I(t) + J(t))F (t)}
+ A4(t){ β
N(t)
(I(t) + J(t))(S(t) + V (t) + F (t))− kE(t)}
+ A5(t){kE(t)− (α + γ1)I(t))}
+ A6(t){αI(t)− (γ2 + δ)J(t)}
+ A7(t){u(t)S(t)}
From this Hamiltonian and Pontryagins Maximum Principle, we obtain
There exist the optimal control u∗(t) and corresponding state solutions, X∗= (S∗, V ∗,
F ∗, P ∗, E∗, I∗, J∗, R∗, D∗) that minimize F(u(t)) over Ω. In order for the above
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statement to be true, it is necessary that there exist adjoint variables Ai(t) such that
A˙1 = −[A1(u(t)− A1 β
N(t)
(I(t) + J(t)) + A2(u(t)) (A.2)
+ A3((1− )u(t) + A4 β
N(t)
(I(t) + J(t)) + A7u(t)]
A˙2 = −[A2 − η + A2(− β
N(t)
(I(t) + J(t))) + A4
β
N(t)
(I(t) + J(t))]
A˙3 = −[−A3 β
N(t)
(I(t) + J(t)) + A4
β
N(t)
(I(t) + J(t))]
A˙4 = −[A4(−k) + A5k]
A˙5 = −[1− A1 β
N(t)
S(t)− A2 β
N
V (t)− A3 β
N(t)
F (t)
+ A4
β
N(t)
(S(t) + V (t) + F (t))− A5(α + γ1) + A6α]
A˙6 = −[−A1 β
N(t)
S(t)− A2 β
N(t)
V (t) + A3
β
N(t)
(F (t))
− A4 β
N(t)
(S(t) + V (t) + F (t))− A6(γ2 + δ)]
A˙7 = 0
satisfying the transversality conditions,
Ai(T ) = 0, i = 1, · · · , 6 (A.3)
A7(T ) = θ. (A.4)
The Hamiltonian H is minimized with respect to the control (at the optimal control).
We differentiate H with respect to u on the set Ω and arrive at the following optimality
condition:
∂H
∂u
= Wu(t)− A1(t)S(t) + S(t)A2(t) + (1− )A3(t)S(t) + A7(t)S(t). (A.5)
Solving for u∗ (by evaluating ∂H
∂u
at u∗), the optimality condition
u(t) =
S(t)
W
(A1(t)− A2(t)− (1− )A3(t) + A7(t)) (A.6)
is obtained. Furthermore, using the standard argument for control bounds, we arrive
at the following expression for the optimal control function
u∗(t) = min
{
max
{
0,
S(t)
W
(A1(t)− A2(t)− (1− )A3(t) + A7(t))
}
, b
}
. (A.7)
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Table A.1: Parameter Definitions and Baseline Values (and their Corresponding Sources)
Used in Numerical Simulations.
Parameter Description Values Reference
β Transmission rate (days−1) 0.75− 1.68 [21]
k Rate of progression to infectious (days−1) 0.53 [63]
δ Mortality rate (days−1) 0.01 [37]
γ1 Recovery rate (days
−1) for infectious class
(days−1)
0.34 [21]
γ2 Recovery rate for hospitalized class (days
−1) 1.10 [21]
α Diagnostic rate (days−1) 0.51 [21]
 Efficacy of vaccination 0.5 [58]
S(0) Initial number of susceptible individuals 174673 [21]
E(0) Initial number of exposed individuals 207 [21]
I(0) Initial number of infectious individuals 132 [21]
T The simulated time (days) 200 -
b The upper bound of control .05− 0.2 -
W Weight constant on control 100 -
The unconstrained solution can be computed by solving the optimality system
which excludes the Y˙ (t) equation in (1) and the A7(t) equation in (7). The standard
two point boundary method is used to solve the unconstrained problem: first, the
state system is solved using a forward method with given initial conditions; secondly,
the corresponding adjoint system is solved using a backward scheme with the transver-
sality conditions; thirdly, a convex combination of previously and currently computed
controls are used to generate updated controls using the optimality equations; lastly,
the process is repeated until a convergence criterion is satisfied.
For, the constrained optimization problem, a new state variable, Y (t) is introduced
in (1) from the isoperimetric constraint (5), which requires boundary conditions at
t = 0 and t = T . From the requirements on Y (t), the corresponding adjoint variable
to Y (t) must meet a non-zero transversality condition at the final time T , namely that
A7(T ) ≡ θ. Note that θ is unknown therefore, an iteration process is needed to find the
right transversality condition required to satisfy the isoperimetric constraint (Y (T ) =
B). This additional iteration process uses Newton’s method and the procedure used
to implement it numerically identifies convergence issues that were never generated
in the search of solutions for the unconstrained problem.
The figure A.1 shows the optimal control functions over time when R0 = 1.3 and
R0 = 2.0. In this case the corresponding daily incidence rate in the infected class is
compared to the situation in the absence of vaccines.
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Figure A.1: The Optimal Control Functions over Time are Plotted When R0 = 1.3 and
R0 = 2.0.
Figure A.2 shows the comparison of results identifying optimal vaccination policies
using different weight constants on the control (W = 1, 102, 104, 106) when R0 =
1.3. The optimal controls and the corresponding incidence of infected individuals are
illustrated (left). The fraction of the cumulative number of infected and vaccinated
individuals are plotted under different weight constants as a function of R0 (right).
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Figure A.2: Optimal Vaccination Policies Results using Different Weight Constants on
the Control (W = 1, 102, 104, 106) when R0 = 1.3.
Figure A.3 shows the results of implementing optimal vaccination strategies when
different upper control bounds (b = 0.05, 0.1, 0.2, 0.5) are used with R0 = 1.3. The
optimal controls and the corresponding incidence of infected individuals are illustrated
(left). The fraction of the cumulative number of infected and vaccinated individuals
are plotted for distinct upper bounds as a function of R0. (right).
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Figure A.3: Optimal Vaccination Strategies Results when Different Upper Control
Bounds (b = 0.05, 0.1, 0.2, 0.5) are used with R0 = 1.3.
Figure A.4 shows the results of implementing optimal vaccination policies under
distinct vaccine efficacy constants on the control ( = 0.4, 0.6, 0.8, 1) when R0 =
1.3. The optimal controls and the corresponding incidence of infected individuals
are plotted (left). The fraction of the cumulative number of infected and vaccinated
individuals are shown for different efficacy levels as a function of R0 (right).
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Figure A.4: Optimal Vaccination Policies under Distinct Vaccine Efficacy Constants on
the Control ( = 0.4, 0.6, 0.8, 1) when R0 = 1.3.
Figure A.5 shows the optimal control functions plotted when b=0.05 (left) and
b=0.2 (right) under three different vaccination coverage (15%, 30%, and 50%). The
corresponding daily incidence in the infected class is compared with the one in the
absence of vaccines.
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Figure A.5: Optimal Control Functions Plotted When b=0.05 (left) and b=0.2 (right)
under Three Different Vaccination Coverage (15%, 30%, and 50%).
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Figure A.6 shoes the raction of the cumulative number of infected individuals
as a function of R0 is compared with the one under no vaccines using two different
vaccination coverage levels (30% and 50%).
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Figure A.6: Fraction of Cumulative Number of Infected Individuals as a Function of R0
Compared with and without Vaccines.
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APPENDIX B
MATHEMATICAL COMPUTATIONS
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The contact matrix used in the age-structured dynamics model (Equation 3.1) is
commuted from the survey data as follows:
1. For each individual the number of daily contacts were computed.
2. An average number of contacts for a specific age is calculated using data from
step 1 and age of individuals
3. Age-groups are constructed and an average contacts per age-group using step 2
are computed
Figure B.1 shows the diagram to formulate the contact matrix. To the left is the
participant id and the average age of the individuals he contacted in a given day, the
column to the right is the participant key id and age.
Figure B.1: Diagram to Formulate Contact Matrix .
B.1 R0 Computation
Using the Next generation Operator we obtain:
F = [qSi
m∑
j=1
pij
Ij
Nj
] (B.1)
F =

qS1
p1
N1
qS1
p2
N2
qS1
p3
N3
. . . qS1
pm
Nm
qS2
p1
N1
qS2
p2
N2
qS2
p3
N3
. . . qS2
pm
Nm
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
qSm
p1
N1
qSm
p2
N2
qSm
p3
N3
. . . qSm
pm
Nm

V =
 γ1I1γ2I2. . . . .
γmIm

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V =

γ1 0 0 . . . 0
0 γ2 0 . . . 0
...
...
...
. . .
...
0 0 0 . . . γm

FV −1 =

qS1
p1
N1
γ1
qS1
f2
N2
γ2
qS1
f3
N3
γ3
. . .
qS1
pm
Nm
γm
qS2
p1
N1
γ1
qS2
p2
N2
γ2
qS2
p3
N3
γ3
. . .
qS2
pm
Nm
γm
...
...
...
. . .
...
qSm
p1
N1
γ1
qSm
p2
N2
γ2
qSm
p3
N3
γ3
. . .
qSm
pm
Nm
γm

Taking the maximum eigenvalue of FV −1 we obtain:
For 2 Age groups:
R0 =
q(p2γ1 + p1γ2)
γ1γ2
(B.2)
For 3 Age groups:
R0 =
q(p2γ1γ3 + p1γ2γ3 + p3γ1γ2)
γ1γ2γ3
(B.3)
For 4 Age groups:
R0 = q
∑4
i 6=j 6=k 6=l piγjγkγl∏4
n=1 γn
(B.4)
B.2 Final Epidemic Size
The expression for final size of an epidemic was computed using equations of the
system and the steps are as follows:
˙Si(t) = −qSi(t)
m∑
j=1
pij
Ij(t)
Nj∫ ∞
0
˙Si(t)dt = −
∫ ∞
0
qSi(t)
m∑
j=1
pij
Ij(t)
Nj
dt
∫ ∞
0
S˙i(t)
Si(t)
dt = −
∫ ∞
0
q
m∑
j=1
pij
Ij(t)
Nj
dt (B.5)
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In this case we observe that Ri(∞)−Ri(0) = Zi = Si(0)− Si(∞) so we obtain
ln
Si(0)
Si(∞) = −q
∫ ∞
0
m∑
j=1
pij
Ij(t)
Nj
dt
ln(−Zi) = −q
∫ ∞
0
m∑
j=1
pij
Ij(t)
Nj
dt (B.6)
Given that we have the integral of I we proceed to solve for ˙Ri(t) equation and
we obtain: ∫ ∞
0
˙Ri(t) =
∫ ∞
0
γIi(t)dt
Ri(∞)−Ri(0) =
∫ ∞
0
γIi(t)dt
Zi
γ
=
∫ ∞
0
Ii(t)dt (B.7)
Putting all back to the Susceptible equation we obtain:
ln(−Zi) = −q
∫ ∞
0
m∑
j=1
pij
Nj
Zj
γ
dt
ln
Si(0)
Si(∞) = −q
m∑
j=1
pij
Nj
Sj(0)− Sj(∞)
γ
(B.8)
B.3 Algorithm to group Participants by their Age and Contacts
1. Construct age groups (say,. 0-25 26-50 51-100; 3 age groups)
2. Use the survey data provided and match the age of the participant with the
group division it belongs to (ie. an individual of age 22 can belong on the age
group from 0-25)
3. Use survey data and match the age of the individuals with whom the participant
had contact with
4. Store the information in a matrix that shows the number of contacts of indi-
viduals in one age-group with individuals that belong to a different age-group.
B.4 Algorithm to Construct Mixing Matrix
The pseudocode for the extraction of the data from the survey data: Steps:
1. Initialize the average number of contact parameter for each of the age groups
2. Initialize the proportion of the population for each of the age groups.
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3. Write in the population proportion or weight for each age from the data
4. Initialize an age vector from 0-99
5. Initialize an age vector from 1-100
6. Construct a 0 matrix
7. Populate the matrix with the data from the survey times the proportion ( the
weight) of the population of each age
Matrixrecip =

C11w1 C12w1 C13w1 . . . C1mw1
C21w2 C22w2 C23w2 . . . C2mw2
...
...
...
. . .
...
Cm1wm Cm2wm Cm3wm . . . Cmmwm

8. Initialize the end points for each of the age groups
9. Sum all the weights of the population that is contained in the same age group
(ie. for a 2 age group example
∑20
j=0 wj for the age group [0-20] , and
∑100
j=10wj
for age group [21-100])
10. Make sure that reciprocity is taken into accounts (ie. contacts that kids have
with adults should be the same as the adults have with kids)
(a) Using the information stored in the Matrixrecip which contains all the 100
by 100 bins
i. Do a for loop i where you go over the starting point of age group i and
end at the starting point of the next age group(i.e. from vector 0-99
we want the group from 0-20 and 21-99 and from vector 1-100 we will
divide 1-21 and 22-100)
ii. Do a for loop j where you go over the starting point of age group j and
end at the starting point of the next age group
iii. Form a smaller matrix with each of the corresponding groups(From
our two age group example we obtain)
Matrixrecip =

C1,1 C1,2 . . . C1,20... ... . . . ...
C20,1 C20,2 . . . C20,20
 C1,21 C2,22 . . . C1,100... ... . . . ...
C20,21 C20,22 . . . C20,100

C21,1 C21,2 . . . C21,20... ... . . . ...
C100,1 C100,2 . . . C100,20
C21,21 C21,22 . . . C21,100... ... . . . ...
C100,21 C100,22 . . . C100,100


iv. Sum all the values in each of the smaller matrices and store [∑20i=1∑20j=1 Ci,j] [∑20i=1∑100j=21 Ci,j][∑100
i=21
∑20
j=1 Ci,j
] [∑100
i=21
∑100
j=21 C1,2Ci,j
]
v. Repeat until there are no more age groups
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(b) Divide each element of the matrix by its corresponding age weight: this
will be NewMatrix
NewMatrix =
[∑20i=1∑20j=1 Ci,j∑20i=1 wi ] [∑20i=1∑100j=21 Ci,j∑20i=1 wi ][∑100
i=21
∑20
j=1 Ci,j∑100
i=21 wi
] [∑100
i=21
∑100
j=21 C1,2Ci,j∑100
i=21 wi
]

(c) Divide the proportion of the population of age group i by the weight of
age group i and label as fractionPop
(d) multiply the NewMatrix by the fractionPop
11. Add all the new information on the matrix output
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APPENDIX C
CONTROL FRAMEWORK
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C.1 CDC Age Group Framework
The optimal control obtained from the model analysis are shown in the figures
below. the goal is to show the difference between models results when mixing matrices
was directly estimated from data (Mossong et al. 2008). The notation TN stands for
mean value of average number of contacts rates per age-groups where its distribution
is assumed to be Normal.
0 10 20 30 40
0.
00
0.
05
0.
10
0.
15
0.
20
 Control Output
Time, in days
Co
nt
ro
l a
ge
 g
ro
up
s
ControlTN_G1
ControlTN_G2
ControlTN_G3
Control_Mossong_G1
Control_Mossong_G2
Control_Mossong_G3
Control_SDPM_G1
Control_SDPM_G2
Control_SDPM_G3
Figure C.1: Control Output to Minimize Infection with 3 Age Groups and with each
Mixing Assumption.
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Figure C.2: Control Output to Minimize Infection with 4 Age Groups and with each
Mixing Assumption.
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Figure C.3: Control Output to Minimize Infection with 5 Age Groups and with each
Mixing Assumption.
The graph below shows the incidence curve using each one of the approaches.
For the case of the TNPM we took the average of all the replicates. We observe
that the incidence over time is very similar when we have two age groups divisions.
However as we increase the number of age groups we notice the incidence output
similarities between the Mossong grouping and the TNPM approach. We can infer
that the difference might decrease as we increase the number of age groups given the
reduction in the density of contacts.
Figure C.4: Output of The Incidence Over Time of Infected Individuals from Age Group
1 to 6 using the 3 Different Approaches.
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The graph below shows the incidence over time for each particular approach. We
plotted all the age groups simulations. Given that age group 2 was very high, we
plotted the rest of the incidence by age excluding age group 2. With the Mossong
approach and the SDPM approach we observed that we have the same qualitative
behavior among all age groups.
Figure C.5: Output of Infected Individuals Separated by Case.
The graphs below show the replicates of the incidence plots over time using the
TNPM approach when two age-groups are considered in the model. We present
graphs as we increase the age groups from 2 to 6.
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Figure C.6: Output of Infected Replicates for Age Group 2 .
Figure C.7: Output of Infected Replicates for Age Group 3 .
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Figure C.8: Output of Infected Replicates for Age Group 4 .
Figure C.9: Output of Infected Replicates for Age Group 5 .
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Figure C.10: Output of Infected Replicates for Age Group 6 .
C.2 Lee et al. Age Group Framework
The graph below we show the relative cost difference when we follow the age group
arrangement for Lee et al. The relative cost difference in both cases increases as we
increase the number of age groups. The trend can be appreciated from the graph to
the right. The difference using the SDPM vs Mossong regroup data is smaller in the
first 4 age groups divisions.
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Figure C.11: Relative Cost Difference Between Models using Contact Matrix from
Mossong et al. and Contact Matrix that uses Proportionate Mixing Formulations.
Figure C.12: Output of Infected Individuals Separated by Case.
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Figure C.13: Output of Infected Individuals from Age Group 1 to 7 using the 3 Different
Approaches.
Figure C.14: Output of Infected Replicates for Age Group 2 .
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Figure C.15: Output of Infected Replicates for Age Group 3 .
Figure C.16: Output of Infected Replicates for Age Group 4 .
80
Figure C.17: Output of Infected Replicates for Age Group 5 .
Figure C.18: Output of Infected Replicates for Age Group 6 .
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C.3 Isoperimetric Constraint
In this case we will evaluate the case when we have limited resources for example,
the Objective Function is:
min
ui
∫ T
0
m∑
i=1
(Ii + u
2
i
W
2
)dt (C.1)
Subject to the state equations
S˙i = −uiSi − qSi
m∑
j=1
fij
Ij
Nj
I˙i = qSi
m∑
j=1
fij
Ij
Nj
− γiIi − σiIi
R˙i = uiSi + γiIi
(C.2)
and the isoperimetric constraint (limited vaccines)∫ T
0
m∑
i=1
(Siu
2
i
W
2
)dt = B (C.3)
In this case B is the maximum amount of vaccines available.
In order to be able to analyze the optimal control problem with the constraint
we cannot use the Pontryagins Max principle. So we introduce an additional state
variable z, where z˙ is
z˙ =
m∑
i=1
uiSi
z(t0) = 0
z(tF ) = B
(C.4)
Using the Pontryagin’s Maximum Principle [79]. This principle converts ODE
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Systems and Constraints into minimizing the Hamiltonian H given by
H =
m∑
i=1
[Ii(t) +
Wi
2
u2i (t)] (C.5)
+
m∑
i=1
λSi [−uiSi − qSi
m∑
j=1
fij
Ij
Nj
]
+
m∑
i=1
λIi [qSi
m∑
j=1
fij
Ij
Nj
− γiIi − σiIi]
+
m∑
i=1
λRi [uiSi + γiIi]
+
m∑
i=1
λzuiSi
where m is the number of age groups.
∂H
∂Si
= −[(−ui − qiSi
m∑
j=1
fij
Ij
Nj
)λSi + (qiSi
m∑
j=1
fij
Ij
Nj
)λIi + uiλRi + uiλz]
∂H
∂Ii
= −[1− (qiSi fii
Ni
)λSi + (qiSi
fii
Ni
− γi − δi)λIi + γiλRi + δiλDi ]
∂H
∂Ri
= 0
∂H
∂z
= 0 (C.6)
The Hamiltonian H is minimized with respect to the control (at the optimal
control). We differentiate H with respect to u on the set Ω and arrive at the following
optimality condition:
∂H
∂µi
= uiW − λSiSi
µi∗ = λSi
Si
W
(C.7)
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